[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 122
1. Dartnell J, Pilling J, Ferner R, Cane P, Lang-Lazdunski L: Malignant triton tumor of the brachial plexus invading the left thoracic inlet: a rare differential diagnosis of pancoast tumor. J Thorac Oncol; 2009 Jan;4(1):135-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant triton tumor of the brachial plexus invading the left thoracic inlet: a rare differential diagnosis of pancoast tumor.
  • Malignant triton tumor is a divergent malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation.
  • We report a case of malignant triton tumor arising in the brachial plexus of a 28-year-old women with neurofibromatosis type 1.
  • Fluorodeoxyglucose-positron emission tomography-computed tomography before excision demonstrated a tumor with a maximum standard uptake value of 21 at 4 hours postinjection.
  • The patient underwent complete excision of the tumor through median sternotomy and left supraclavicular approach.
  • [MeSH-major] Brachial Plexus / pathology. Neurilemmoma / diagnosis. Pancoast Syndrome / diagnosis. Peripheral Nervous System Neoplasms / diagnosis. Thoracic Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Fatal Outcome. Female. Fluorodeoxyglucose F18. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Neurofibromatosis 1 / complications. Positron-Emission Tomography. Radiopharmaceuticals. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19096322.001).
  • [ISSN] 1556-1380
  • [Journal-full-title] Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • [ISO-abbreviation] J Thorac Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


2. Karube K, Nabeshima K, Ishiguro M, Harada M, Iwasaki H: cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol; 2006 Feb;59(2):160-5
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.
  • BACKGROUND: Malignant peripheral nerve sheath tumour (MPNST) is a highly aggressive malignancy that arises within peripheral nerves, and is associated with poor prognosis.
  • Little is known about the underlying biology of MPNST, especially the mechanisms involved in cell proliferation, invasion, or escape from apoptosis.
  • AIMS: To identify genes differentially expressed in MPNST compared with benign tumours, such as neurofibromas and schwannomas, by means of cDNA microarray analysis.
  • METHODS: Six MPNST cases and five benign cases (three schwannomas and two neurofibromas) were analysed.
  • RESULTS: Six genes (keratin 18, survivin, tenascin C, adenosine deaminase, collagen type VIa3, and collagen type VIIa1) were significantly upregulated in MPNST, whereas one gene, insulin-like growth factor binding protein 6, was downregulated in MPNST.
  • Immunohistochemistry confirmed upregulation of survivin in MPNST at the protein level in six of eight cases compared with benign tumours.
  • Tenascin C was also expressed at the invasive front and tumorous stroma in all MPNST cases.
  • MPNST cells expressed tenascin C in four of nine cases.
  • CONCLUSIONS: Survivin and tenascin C may be associated with the malignant potential of MPNST and could be considered as potential therapeutic targets.
  • [MeSH-major] Gene Expression Regulation, Neoplastic. Neoplasm Proteins / biosynthesis. Nerve Sheath Neoplasms / metabolism. Peripheral Nervous System Neoplasms / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Gene Expression Profiling / methods. Humans. Immunoenzyme Techniques. Inhibitor of Apoptosis Proteins. Male. Microtubule-Associated Proteins / biosynthesis. Microtubule-Associated Proteins / genetics. Middle Aged. Neurilemmoma / genetics. Neurilemmoma / metabolism. Neurilemmoma / pathology. Neurofibroma / genetics. Neurofibroma / metabolism. Neurofibroma / pathology. Oligonucleotide Array Sequence Analysis / methods. Reverse Transcriptase Polymerase Chain Reaction / methods. Tenascin / biosynthesis. Tenascin / genetics. Up-Regulation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Cell Biol. 1999 Dec;1(8):461-6 [10587640.001]
  • [Cites] J Clin Invest. 1991 Feb;87(2):648-57 [1991849.001]
  • [Cites] J Cell Physiol. 2000 Apr;183(1):1-9 [10699960.001]
  • [Cites] Ann Oncol. 2000;11 Suppl 1:127-30 [10707794.001]
  • [Cites] Growth Horm IGF Res. 2000 Dec;10(6):349-59 [11161966.001]
  • [Cites] J Clin Invest. 2001 Oct;108(7):965-9 [11581297.001]
  • [Cites] Hum Pathol. 1991 Jul;22(7):636-43 [1712747.001]
  • [Cites] Neuron. 1992 Mar;8(3):415-28 [1550670.001]
  • [Cites] Growth Regul. 1991 Sep;1(3):125-30 [1726837.001]
  • [Cites] Annu Rev Physiol. 1993;55:131-53 [8466170.001]
  • [Cites] Cell Biol Int. 1993 Mar;17(3):325-9 [7685649.001]
  • [Cites] Pathol Res Pract. 1994 Apr;190(4):412-5 [8078812.001]
  • [Cites] Experientia. 1995 Sep 29;51(9-10):853-62 [7556567.001]
  • [Cites] Cancer Res. 1996 Oct 1;56(19):4522-9 [8813151.001]
  • [Cites] Clin Cancer Res. 1996 Nov;2(11):1879-85 [9816144.001]
  • [Cites] Cancer Res. 1998 Nov 15;58(22):5071-4 [9823313.001]
  • [Cites] Nature. 1998 Dec 10;396(6711):580-4 [9859993.001]
  • [Cites] Br J Cancer. 2005 Jan 17;92(1):120-4 [15611790.001]
  • [Cites] Trends Mol Med. 2001 Dec;7(12):542-7 [11733216.001]
  • [Cites] Diagn Mol Pathol. 2002 Mar;11(1):33-40 [11854600.001]
  • [Cites] J Clin Oncol. 2002 Mar 1;20(5):1389-97 [11870184.001]
  • [Cites] J Pathol. 2002 Jul;197(3):388-94 [12115886.001]
  • [Cites] Blood. 2003 Feb 15;101(4):1535-42 [12393476.001]
  • [Cites] Histopathology. 2003 Mar;42(3):280-91 [12605648.001]
  • [Cites] J Neurooncol. 2003 May;62(3):321-8 [12777085.001]
  • [Cites] Int J Cancer. 2003 Sep 20;106(5):706-12 [12866030.001]
  • [Cites] Clin Exp Dermatol. 2003 Sep;28(5):515-20 [12950343.001]
  • [Cites] Mod Pathol. 2003 Oct;16(10):1019-27 [14559985.001]
  • [Cites] BMC Dev Biol. 2001;1:5 [11305929.001]
  • [Cites] J Pathol. 2003 Nov;201(3):430-8 [14595755.001]
  • [Cites] J Clin Oncol. 2003 Dec 15;21(24):4586-91 [14673046.001]
  • [Cites] Int J Oncol. 2004 Mar;24(3):529-38 [14767537.001]
  • [Cites] Cancer. 1986 May 15;57(10):2006-21 [3082508.001]
  • [Cites] Cell. 1990 Jul 13;62(1):187-92 [1694727.001]
  • [Cites] Science. 1990 Jul 13;249(4965):181-6 [2134734.001]
  • [Cites] Oncogene. 2000 Feb 3;19(5):617-23 [10698506.001]
  • (PMID = 16443732.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; 0 / Neoplasm Proteins; 0 / Tenascin
  • [Other-IDs] NLM/ PMC1860323
  •  go-up   go-down


3. Chiou HJ, Chou YH, Chiu SY, Wang HK, Chen WM, Chen TH, Chang CY: Differentiation of benign and malignant superficial soft-tissue masses using grayscale and color doppler ultrasonography. J Chin Med Assoc; 2009 Jun;72(6):307-15

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differentiation of benign and malignant superficial soft-tissue masses using grayscale and color doppler ultrasonography.
  • BACKGROUND: This study was performed to evaluate the usefulness of high-resolution grayscale and color Doppler ultrasound to distinguish benign from malignant soft-tissue masses on the basis of ultrasonographic patterns.
  • RESULTS: There were a total of 693 benign and 125 malignant masses.
  • Five malignant and 14 benign histologies (including 6 types with inflammation-related, hematoma or pseudoaneurysm) occurred that had more than 10 subjects with each histology.
  • Five malignant histologies included metastases, osteogenic sarcomas, lymphomas, malignant fibrous histiocytomas and liposarcomas.
  • There were significant differences (p < 0.05) between the benign and malignant soft-tissue tumors in terms of parameters including tumor margin, shape and size.
  • Benign lesions did not have infiltrated margins or a scalloped shape and malignant tumors tended to be large.
  • However, there was no significant difference (p > 0.05) between the benign and malignant soft-tissue tumors in terms of echogenicity, composition and color Doppler features.
  • CONCLUSION: Ultrasonography with color Doppler imaging is a good modality for characterizing most soft-tissue masses, and tumor size > 5 cm and having infiltrated margin highly suggests malignancy.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Epidermal Cyst / pathology. Epidermal Cyst / ultrasonography. Female. Giant Cell Tumors / pathology. Giant Cell Tumors / ultrasonography. Hemangioma / pathology. Hemangioma / ultrasonography. Humans. Infant. Liposarcoma / pathology. Liposarcoma / ultrasonography. Male. Middle Aged. Neoplasm Metastasis. Neurilemmoma / pathology. Neurilemmoma / ultrasonography. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19541566.001).
  • [ISSN] 1726-4901
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


Advertisement
4. Stojanovic MP, Radojkovic M, Jeremic LM, Zlatic AV, Stanojevic GZ, Jovanovic MA, Kostov MS, Katic VP: Malignant schwannoma of the pancreas involving transversal colon treated with en-bloc resection. World J Gastroenterol; 2010 Jan 7;16(1):119-22
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant schwannoma of the pancreas involving transversal colon treated with en-bloc resection.
  • Pancreatic schwannoma is a very uncommon tumor of the pancreas, with only 27 cases reported.
  • Most pancreatic schwannomas are benign, with only four malignant tumors reported.
  • We describe a case of giant malignant schwannoma of the pancreatic body and tail, which involved the transverse colon.
  • The tumor was treated successfully with en bloc distal splenopancreatectomy and colon resection.
  • This is believed to be the first reported radical operation for malignant schwannoma of the pancreatic body, with infiltration of the transverse colon, with excellent long-term results.
  • In the case of the benign tumors, local excision is adequate, but in the case of malignant schwannoma, oncological standards must be fulfilled.
  • [MeSH-major] Colectomy. Colon / surgery. Neurilemmoma / surgery. Pancreatectomy. Pancreatic Neoplasms / surgery
  • [MeSH-minor] Biopsy. Female. Humans. Lymph Node Excision. Neoplasm Invasiveness. Splenectomy. Tomography, X-Ray Computed. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Today. 1999;29(10):1093-7 [10554337.001]
  • [Cites] Ann Diagn Pathol. 2008 Aug;12(4):296-300 [18621000.001]
  • [Cites] J Neurosurg. 2003 Oct;99(4):685-92 [14567604.001]
  • [Cites] Ann Diagn Pathol. 2003 Oct;7(5):285-91 [14571430.001]
  • [Cites] Surg Today. 2004;34(6):550-3 [15170556.001]
  • [Cites] Acta Chir Scand. 1982;148(8):697-8 [7170905.001]
  • [Cites] J Surg Oncol. 1987 Sep;36(1):21-5 [3626558.001]
  • [Cites] Gastroenterology. 1989 Dec;97(6):1550-1 [2511055.001]
  • [Cites] Semin Roentgenol. 1990 Apr;25(2):127-9 [2112269.001]
  • [Cites] AJR Am J Roentgenol. 1992 Sep;159(3):675 [1503050.001]
  • [Cites] AJR Am J Roentgenol. 1992 Nov;159(5):1023-6 [1414767.001]
  • [Cites] AJR Am J Roentgenol. 1995 Jul;165(1):232 [7785620.001]
  • [Cites] Pancreas. 1997 Jul;15(1):99-105 [9211499.001]
  • [Cites] Cytopathology. 1999 Jun;10(3):186-94 [10390067.001]
  • [Cites] JOP. 2004 Nov;5(6):520-6 [15536295.001]
  • [Cites] Clin Imaging. 2005 Nov-Dec;29(6):434-6 [16274899.001]
  • [Cites] J Comput Assist Tomogr. 2000 Jul-Aug;24(4):622-7 [10966199.001]
  • (PMID = 20039458.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2799907
  •  go-up   go-down


5. Santaella Y, Borrego I, López J, Ortiz MJ, Vázquez R: [18-FDG-PET in a case of recurrent malignant schwannoma]. Rev Esp Med Nucl; 2005 Mar-Apr;24(2):127-30
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [18-FDG-PET in a case of recurrent malignant schwannoma].
  • [Transliterated title] Diagnóstico de recurrencia mediante FDG-PET en un caso clínico de schwannoma maligno.
  • The peripheral nerve sarcoma, also called malignant schwannoma, is originally a soft tissue sarcoma.
  • It is mainly located in the peripheral sheath nerve of the limbs and usually infiltrates the nerve fibres.
  • We present the case of a thirty year old woman with a malignant schwannoma in her left leg sciatic nerve who had been treated on several occasions.
  • PET can be a useful technique to detect recurrence for this kind of tumor, mainly in patients who have been previously radiated when the MRI is insufficient to perform a differential diagnosis between postirradiation fibrosis and tumoral recurrence, allowing for suitable therapeutic management of the patient.
  • [MeSH-major] Fluorodeoxyglucose F18. Neurilemmoma / radionuclide imaging. Peripheral Nervous System Neoplasms / radionuclide imaging. Positron-Emission Tomography. Radiopharmaceuticals. Sciatic Neuropathy / radionuclide imaging
  • [MeSH-minor] Adult. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15745683.001).
  • [ISSN] 0212-6982
  • [Journal-full-title] Revista española de medicina nuclear
  • [ISO-abbreviation] Rev Esp Med Nucl
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


6. Benz MR, Czernin J, Dry SM, Tap WD, Allen-Auerbach MS, Elashoff D, Phelps ME, Weber WA, Eilber FC: Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer; 2010 Jan 15;116(2):451-8
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
  • BACKGROUND: Correct pretreatment classification is critical for optimizing diagnosis and treatment of patients with peripheral nerve sheath tumors (PNSTs).
  • The aim of this study was to evaluate whether F18-fluorodeoxyglucose positron emission tomography (FDG PET) can differentiate malignant (MPNST) from benign PNSTs.
  • METHODS: Thirty-four adult patients presenting with PNST who underwent a presurgical FDG PET/computed tomography (CT) scan between February 2005 and November 2008 were included in the study.
  • Tumors were characterized histologically, by FDG maximum standardized uptake value (SUV(max) [g/mL]), and by CT size (tumor maximal diameter [cm]).
  • The accuracy of FDG PET for differentiating MPNSTs from benign PNSTs (neurofibroma and schwannoma) was evaluated by receiver operating characteristic (ROC) curve analysis.
  • SUV(max) was significantly higher in MPNST compared with benign PNST (12.0 +/- 7.1 vs 3.4 +/- 1.8; P < .001).
  • By ROC curve analysis, SUV(max) reliably differentiated between benign and malignant PNSTs (area under the ROC curve of 0.97).
  • Given the difficulties in clinically evaluating PNST and in distinguishing benign PNST from MPNST, FDG PET imaging should be used for diagnostic intervention planning and for optimizing treatment strategies.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Nucl Med. 2001 Oct;28(10):1541-51 [11685498.001]
  • [Cites] Clin Cancer Res. 2009 Apr 15;15(8):2856-63 [19351756.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):542-6 [11914894.001]
  • [Cites] Radiographics. 2003 Jan-Feb;23(1):29-43 [12533638.001]
  • [Cites] Eur J Surg Oncol. 2003 Aug;29(6):536-41 [12875862.001]
  • [Cites] J Nucl Med. 2004 Jan;45 Suppl 1:25S-35S [14736833.001]
  • [Cites] AJR Am J Roentgenol. 2004 Apr;182(4):971-4 [15039173.001]
  • [Cites] J Nucl Med. 2004 May;45(5):797-801 [15136629.001]
  • [Cites] Lab Invest. 1983 Sep;49(3):299-308 [6310227.001]
  • [Cites] Cancer. 1986 May 15;57(10):2006-21 [3082508.001]
  • [Cites] Ann Surg Oncol. 1995 Mar;2(2):126-31 [7728565.001]
  • [Cites] Med Phys. 1998 Oct;25(10):2046-53 [9800714.001]
  • [Cites] J Med Genet. 1999 Mar;36(3):197-203 [10204844.001]
  • [Cites] Ann Oncol. 2004 Nov;15(11):1667-72 [15520069.001]
  • [Cites] Cancer. 2004 Nov 15;101(10):2270-5 [15484214.001]
  • [Cites] J Nucl Med. 2005 Apr;46(4):603-7 [15809482.001]
  • [Cites] Orthop Clin North Am. 2006 Jan;37(1):15-22 [16311108.001]
  • [Cites] Nat Med. 2006 Jan;12(1):122-7 [16341243.001]
  • [Cites] Virchows Arch. 2006 Dec;449(6):673-81 [17103226.001]
  • [Cites] AJR Am J Roentgenol. 2007 Oct;189(4):928-35 [17885067.001]
  • [Cites] Ann Oncol. 2008 Feb;19(2):390-4 [17932395.001]
  • [Cites] Cancer Res. 2002 Mar 1;62(5):1573-7 [11894862.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2000 Mar;68(3):353-7 [10675220.001]
  • [Cites] Eur J Nucl Med. 2000 Oct;27(10):1509-17 [11083540.001]
  • [Cites] J Clin Oncol. 2001 Jul 1;19(13):3203-9 [11432887.001]
  • [Cites] Eur J Nucl Med. 2001 Sep;28(9):1336-40 [11585292.001]
  • [Cites] Clin Cancer Res. 2008 Feb 1;14(3):715-20 [18245531.001]
  • [Cites] J Surg Oncol. 2008 Mar 15;97(4):340-9 [18286466.001]
  • [Cites] J Nucl Med. 2008 Jul;49(7):1038-46 [18552153.001]
  • [Cites] Oral Dis. 2008 Sep;14(6):510-3 [18826382.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2009 May;36(5):751-7 [19142634.001]
  • [ErratumIn] Cancer. 2010 Feb 1;116(3):775
  • (PMID = 19924789.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P50 CA086306; United States / NCI NIH HHS / CA / 5 P50 CA086306
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Other-IDs] NLM/ NIHMS324300; NLM/ PMC3188986
  •  go-up   go-down


7. Nabeshima K, Iwasaki H, Nishio J, Koga K, Shishime M, Kikuchi M: Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential. Anticancer Res; 2006 Mar-Apr;26(2B):1359-67
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.
  • However, their roles in peripheral nerve sheath tumors (PNSTs) have rarely been investigated.
  • MATERIALS AND METHODS: In this study, the immunohistochemical expression of 6 MMPs, their 3 inhibitors and emmprin, an MMP inducer, was examined in 14 schwannomas, 14 neurofibromas and 12 malignant peripheral nerve sheath tumors (MPNSTs) in relation to malignant potentials.
  • Moreover, the expression patterns of MMP-1 and gelatinase B (MMP-9) could divide PNSTs into two groups: schwannoma versus neurofibroma/MPNST.
  • CONCLUSION: These results suggest that emmprin and MT1-MMP may be malignant potential-related proteins in PNSTs, and that MMP-1 and 9 may help differentiation between schwannoma and neurofibroma, especially in their plexiform types.
  • [MeSH-major] Antigens, CD147 / biosynthesis. Matrix Metalloproteinases / biosynthesis. Nerve Sheath Neoplasms / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Female. Humans. Immunohistochemistry. Isoenzymes / biosynthesis. Male. Matrix Metalloproteinases, Membrane-Associated. Middle Aged. Neurilemmoma / enzymology. Neurilemmoma / metabolism. Neurilemmoma / pathology. Neurofibroma / enzymology. Neurofibroma / metabolism. Neurofibroma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16619545.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / BSG protein, human; 0 / Isoenzymes; 136894-56-9 / Antigens, CD147; EC 3.4.24.- / Matrix Metalloproteinases; EC 3.4.24.- / Matrix Metalloproteinases, Membrane-Associated
  •  go-up   go-down


8. Ballesteros F, Vilaseca I, Blanch JL, Gaspa A, Bernal-Sprekelsen M: Base of tongue neurilemmoma: excision by transoral laser microsurgery. Acta Otolaryngol; 2007 Sep;127(9):1005-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Base of tongue neurilemmoma: excision by transoral laser microsurgery.
  • Benign and malignant tumors of the tongue base can be removed by various surgical approaches.
  • A rare case of neurilemmoma of the base of the tongue removed by transoral laser microsurgery (TLM) is presented.
  • [MeSH-major] Laser Therapy / methods. Microsurgery / methods. Neurilemmoma / surgery. Tongue Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Magnetic Resonance Imaging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17712683.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


9. James G, Crocker M, King A, Bodi I, Ibrahim A, Chitnavis BP: Malignant triton tumors of the spine. J Neurosurg Spine; 2008 Jun;8(6):567-73
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant triton tumors of the spine.
  • Malignant triton tumors (MTTs) are malignant peripheral nerve sheath tumors with rhabdomyosarcomatous differentiation.
  • Malignant triton tumors affecting the spine are rare but present special challenges to the neurosurgeon.
  • Nine patients presented with symptoms related to the spinal cord, cauda equina, or nerve root compression.
  • Seven patients had intradural extension of tumor.
  • Malignant triton tumors are rare but should be included in the differential diagnosis of spinal tumors, particularly in patients who have undergone previous radiotherapy or who have neurofibromatosis.
  • [MeSH-major] Neurilemmoma / diagnosis. Spinal Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Desmin / analysis. Diagnosis, Differential. Female. Humans. Ki-67 Antigen / analysis. Lumbar Vertebrae / pathology. Male. Neoplasm Recurrence, Local / diagnosis. S100 Proteins / analysis. Sacrum / pathology. Spinal Canal / pathology. Spinal Cord Compression / diagnosis. Thoracic Vertebrae / pathology. Vimentin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18518679.001).
  • [ISSN] 1547-5654
  • [Journal-full-title] Journal of neurosurgery. Spine
  • [ISO-abbreviation] J Neurosurg Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Desmin; 0 / Ki-67 Antigen; 0 / S100 Proteins; 0 / Vimentin
  • [Number-of-references] 13
  •  go-up   go-down


10. Manganoni AM, Farisoglio C, Lonati A, Zorzi F, Tucci G, Pinton PG: Cutaneous epithelioid malignant schwannoma: review of the literature and case report. J Plast Reconstr Aesthet Surg; 2009 Sep;62(9):e318-21
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous epithelioid malignant schwannoma: review of the literature and case report.
  • A case of malignant epithelioid schwannoma in the skin is reported.
  • This was a rare variant of a malignant tumour that arose on the back of a 35-year-old male without neurofibromatosis.
  • Ultrastructural and immunohistochemical features of the lesion were consistent with those of malignant epithelioid schwannoma so a radical excision was performed.
  • Most ordinary malignant schwannoma are located in the deep soft tissue of the proximal portions of the upper and lower extremities and trunk; to the best of our knowledge only 26 cases of malignant epithelioid schwannoma in the skin and subcutis have been described in the literature.
  • We can conclude that malignant epithelioid schwannoma in the skin and subcutis is eminently curable if treated with wide local excision.
  • [MeSH-major] Epithelioid Cells / pathology. Neurilemmoma / pathology. Skin / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Humans. Male. Treatment Outcome

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18455973.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 11
  •  go-up   go-down


11. Di Giovannantonio L, Bellocci R, Zappacosta R, Zappacosta B, Castrataro A, Liberatore M, Liberati M, Angelucci D: [Primary malignant schwannoma of the uterine cervix: a malignant tumor with unusual behaviour. A case report]. Pathologica; 2005 Feb;97(1):7-9
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary malignant schwannoma of the uterine cervix: a malignant tumor with unusual behaviour. A case report].
  • [Transliterated title] Schwannoma maligno primitivo della cervice uterina: un tumore maligno a comportamento inusuale. Caso clinico.
  • Malignant tumors of peripheral nerves (MPNST) represent approximately 5-10% of all soft tissue sarcomas and usually are in relationship with a major nerve.
  • Primary cervical malignant Schwannomas are very rare neural sheat tumors that, grossly and clinically, are misdiagnosed for other more frequent lesions of the uterine cervix.
  • We report a case of primary cervical malignant Schwannoma in a 27 years old female with atypical bleeding.
  • [MeSH-major] Neurilemmoma / pathology. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Pathologica. 2005 Jun;97(3):159. Zappacosta, B [added]
  • (PMID = 15918410.001).
  • [ISSN] 0031-2983
  • [Journal-full-title] Pathologica
  • [ISO-abbreviation] Pathologica
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 9
  •  go-up   go-down


12. Fukushima S, Kageshita T, Wakasugi S, Matsushita S, Kaguchi A, Ishihara T, Ono T: Giant malignant peripheral nerve sheath tumor of the scalp. J Dermatol; 2006 Dec;33(12):865-8
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant malignant peripheral nerve sheath tumor of the scalp.
  • Herein, we describe a rare case of giant malignant peripheral nerve sheath tumor of the head in a 38-year-old Japanese man.
  • The tumor measured 210 mm at its largest diameter and was ulcerated, hemorrhagic, multilocular and non-mobile.
  • It should be noted that the patient stubbornly refused to see a doctor for a long time, resulting in the extreme growth of the tumor.
  • Dermatohistopathological findings of the biopsy indicated ancient schwannoma and total excision was therefore performed.
  • Post-mortem skin biopsy revealed features of malignant peripheral nerve sheath tumor.
  • We propose that the expressions of Ki67 and p16 should be checked for all lesions of peripheral nerve sheath tumor for distinguishing benign from malignant forms.
  • [MeSH-major] Neurilemmoma / diagnosis. Scalp / pathology. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Biomarkers, Tumor / analysis. Cyclin-Dependent Kinase Inhibitor p16 / analysis. Fatal Outcome. Hemorrhage / pathology. Humans. Ki-67 Antigen / analysis. Male. Skin Ulcer / pathology

  • Genetic Alliance. consumer health - Malignant peripheral nerve sheath tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17169091.001).
  • [ISSN] 0385-2407
  • [Journal-full-title] The Journal of dermatology
  • [ISO-abbreviation] J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / Ki-67 Antigen
  •  go-up   go-down


13. Li CS, Huang GS, Wu HD, Chen WT, Shih LS, Lii JM, Duh SJ, Chen RC, Tu HY, Chan WP: Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging. Clin Imaging; 2008 Mar-Apr;32(2):121-7
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging.
  • PURPOSE: The objective of this study was to differentiate the magnetic resonance (MR) imaging appearance of benign peripheral nerve sheath tumors (PNSTs) from that of malignant PNSTs.
  • MATERIALS AND METHODS: Twenty-six patients who underwent MR imaging and had a histologic diagnosis of benign (schwannoma, n=16; neurofibroma, n=1) or malignant (n=9) PNST were retrospectively reviewed.
  • =2.5 cm) was significantly smaller than that of the malignant tumors (8.2 cm, S.D.
  • Seventeen (65.4%) of the 26 tumors were spindle shaped or ovoid (12 benign and 5 malignant tumors).
  • Contiguity with specific nerves was identified in 15 (88.2%) of the 17 benign PNSTs but in none of the malignant tumors (P<.05).
  • Well-defined margins were noted in all 17 benign PNSTs but in only 3 (33.3%) of the 9 malignant tumors (P<.001).
  • Five (55.6%) of the 9 malignant PNSTs but none of the benign tumors showed signal intensity change in adjacent soft tissue (P<.05).
  • There was no significant difference in signal intensity between the benign and malignant tumors on T(1)-weighted, T(2)-weighted, and contrast-enhanced MR images.
  • The split fat and target signs were present more frequently in the benign PNSTs than in the malignant PNSTs (P<.05).
  • CONCLUSIONS: Benign and malignant PNSTs are often spindle shaped.
  • [MeSH-major] Magnetic Resonance Imaging. Peripheral Nervous System Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Contrast Media. Diagnosis, Differential. Female. Gadolinium DTPA. Humans. Male. Middle Aged. Nerve Sheath Neoplasms / diagnosis. Neurilemmoma / diagnosis. Neurofibroma / diagnosis

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18313576.001).
  • [ISSN] 0899-7071
  • [Journal-full-title] Clinical imaging
  • [ISO-abbreviation] Clin Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


14. Chibbaro S, Herman P, Povlika M, George B: Malignant trigeminal schwannoma extending into the anterior skull base. Acta Neurochir (Wien); 2008 Jun;150(6):599-604
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant trigeminal schwannoma extending into the anterior skull base.
  • Malignant schwannomas are rare tumours that seldom grow in the head and neck and their occurrence is even rarer in patients not affected by neurofibromatosis.
  • The authors report a 40 year old woman with a left trigeminal malignant schwannoma (arising from V2), involving the infratemporal fossa and subsequently extending into the maxillary, sphenoid and ethmoidal sinuses, the orbit, and the intracranial compartment.
  • [MeSH-major] Cranial Fossa, Anterior / surgery. Cranial Nerve Neoplasms / surgery. Neurilemmoma / surgery. Trigeminal Nerve Diseases / surgery
  • [MeSH-minor] Adult. Biopsy. Cooperative Behavior. Disease Progression. Dose Fractionation. Female. Humans. Image Processing, Computer-Assisted. Magnetic Resonance Imaging. Neoadjuvant Therapy. Neoplasm Invasiveness. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Palliative Care. Patient Care Team. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18473115.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


15. Halac M, Cnaral F, Sait S, Ylmaz S, Kerim S, Sergülen D, Uslu I: FDG PET/CT findings in recurrent malignant schwannoma. Clin Nucl Med; 2008 Mar;33(3):172-4
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] FDG PET/CT findings in recurrent malignant schwannoma.
  • Malignant schwannoma is an uncommon but aggressive sarcoma that most commonly arises in young and middle-aged adults.
  • We present a 28-year-old male patient with a recurrent chest wall malignant schwannoma.
  • We conclude that FDG PET/CT could play an important role in the staging, restaging, and post-therapy follow-up of malignant schwannomas.
  • [MeSH-major] Fluorodeoxyglucose F18. Muscle Neoplasms / radiography. Muscle Neoplasms / radionuclide imaging. Neurilemmoma / radiography. Neurilemmoma / radionuclide imaging. Positron-Emission Tomography. Radiopharmaceuticals. Thoracic Wall / radiography. Thoracic Wall / radionuclide imaging. Tomography, Emission-Computed
  • [MeSH-minor] Adult. Axilla / radiography. Axilla / radionuclide imaging. Humans. Male. Neoplasm Recurrence, Local / radiography. Neoplasm Recurrence, Local / radionuclide imaging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18287838.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


16. Schmitz KJ, Unkel C, Grabellus F, Baba HA, Dirsch O, Neumann A: Melanotic schwannoma of the neck mimicking a malignant melanoma. Eur Arch Otorhinolaryngol; 2005 Mar;262(3):182-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanotic schwannoma of the neck mimicking a malignant melanoma.
  • A fine-needle aspiration biopsy performed elsewhere led to the diagnosis of malignant melanoma.
  • Diagnostic exstirpation of the cervical tumor resulted in the intraoperative diagnosis of a malignant melanoma.
  • Subsequent pathological examination including ultrastructural analysis allowed the revision of the diagnosis to that of melanotic schwannoma, a rare, pigmented nerve sheath tumor.
  • With regard to prognostic and therapeutic issues, it is necessary to differentiate these tumors from the more common metastatic malignant melanoma.
  • [MeSH-major] Melanoma / diagnosis. Neurilemmoma / pathology. Pharyngeal Neoplasms / pathology
  • [MeSH-minor] Adult. Biopsy, Needle. Diagnosis, Differential. Female. Humans. Treatment Outcome. Ultrasonography

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Throat Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 2000 Mar;22(2):195-99 [10679907.001]
  • [Cites] Dev Biol. 1977 Oct 1;60(1):217-25 [911400.001]
  • [Cites] Dermatol Clin. 1995 Jan;13(1):19-26 [7712644.001]
  • [Cites] J Pathol Bacteriol. 1961 Oct;82:257-66 [13907991.001]
  • [Cites] Development. 1991 May;112(1):301-5 [1769335.001]
  • [Cites] Histopathology. 1999 Dec;35(6):558-66 [10583580.001]
  • [Cites] Am J Surg Pathol. 1984 Feb;8(2):129-38 [6703189.001]
  • [Cites] Cancer. 1988 Jul 1;62(1):174-83 [3289725.001]
  • [Cites] Arch Pathol Lab Med. 1986 Feb;110(2):153-4 [3753849.001]
  • (PMID = 15133690.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


17. Kellogg A, Watson WJ: Malignant schwannoma in pregnancy: a case report and literature review. Am J Perinatol; 2010 Mar;27(3):201-4
MedlinePlus Health Information. consumer health - Tumors and Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant schwannoma in pregnancy: a case report and literature review.
  • Malignant peripheral nerve sheath tumors in pregnancy are an uncommon finding.
  • Evaluation revealed a large chest mass, biopsy proven to be a malignant schwannoma.
  • This malignant peripheral nerve sheath tumor, discovered at 26 weeks' gestation, grew so rapidly that delivery was necessary at 30 weeks' gestation.
  • [MeSH-major] Lung Neoplasms / pathology. Neoplasms, Second Primary / pathology. Neurilemmoma / pathology. Neurofibromatosis 1 / diagnosis. Pregnancy Complications, Neoplastic / pathology
  • [MeSH-minor] Adult. Bone Neoplasms / secondary. Cesarean Section. Fatal Outcome. Female. Humans. Lymphatic Metastasis. Pregnancy. Pregnancy Outcome. Prenatal Care / methods

  • Genetic Alliance. consumer health - Pregnancy.
  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Thieme Medical Publishers.
  • (PMID = 19688672.001).
  • [ISSN] 1098-8785
  • [Journal-full-title] American journal of perinatology
  • [ISO-abbreviation] Am J Perinatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 8
  •  go-up   go-down


18. Furniss D, Swan MC, Morritt DG, Lim J, Khanna T, Way BL, Athanasou NA, Giele H, Critchley P: A 10-year review of benign and malignant peripheral nerve sheath tumors in a single center: clinical and radiographic features can help to differentiate benign from malignant lesions. Plast Reconstr Surg; 2008 Feb;121(2):529-33
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A 10-year review of benign and malignant peripheral nerve sheath tumors in a single center: clinical and radiographic features can help to differentiate benign from malignant lesions.
  • BACKGROUND: Malignant peripheral nerve sheath tumors are rare, and their aggressive nature mandates treatment in specialist centers.
  • In contrast, benign peripheral nerve sheath tumors are common and are treated by a variety of specialist surgeons, including plastic surgeons.
  • The authors aimed to detect features in the clinical presentation of peripheral nerve sheath tumors that point toward a diagnosis of malignant peripheral nerve sheath tumor and therefore prompt referral to a specialist center.
  • METHODS: All histologically diagnosed primary peripheral nerve sheath tumors from January of 1995 to December of 2004 were identified from histopathology records.
  • RESULTS: During the study period, 32 cases of malignant peripheral nerve sheath tumor in 30 patients were treated.
  • Factors in the clinical evaluation that significantly predicted the presence of malignant peripheral nerve sheath tumor included site, large size, depth in relation to the deep fascia, short duration of symptoms, and pain.
  • Interestingly, schwannomata were harder to distinguish from malignant peripheral nerve sheath tumors both clinically and radiologically.
  • CONCLUSIONS: The authors have reviewed their institutional experience of peripheral nerve sheath tumors over a 10-year period.
  • [MeSH-major] Magnetic Resonance Imaging / methods. Neurilemmoma / diagnosis. Neurofibroma / diagnosis. Peripheral Nervous System Neoplasms / diagnosis. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Retrospective Studies. Sensitivity and Specificity. Time Factors

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18300972.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


19. Shimada S, Tsuzuki T, Kuroda M, Nagasaka T, Hara K, Takahashi E, Hayakawa S, Ono K, Maeda N, Mori N, Illei PB: Nestin expression as a new marker in malignant peripheral nerve sheath tumors. Pathol Int; 2007 Feb;57(2):60-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
  • Malignant peripheral nerve sheath tumor (MPNST) can be difficult to diagnose because it lacks specific immunohistochemical markers.
  • S-100, which is a useful marker of MPNST, has limited diagnostic utility.
  • The diagnostic utility of immunostains for nestin and three other neural markers (S-100, CD56 and protein gene product 9.5 (PGP 9.5)) were evaluated in 35 cases of MPNST and in other spindle cell tumors.
  • All MPNST cases were strongly positive for nestin and had cytoplasmic staining.
  • Nestin was negative in 10/10 leiomyomas, and weak nestin expression was seen in 10/10 schwannomas, 3/10 neurofibromas, 2/8 synovial sarcomas, 2/10 liposarcomas, 4/7 carcinosarcomas and 3/7 malignant fibrous histiocytomas.
  • Nestin is more sensitive for MPNST than other neural markers and immunostains for nestin in combination with other markers could be useful in the diagnosis of MPNST.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Intermediate Filament Proteins / metabolism. Nerve Sheath Neoplasms / metabolism. Nerve Tissue Proteins / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Cauda Equina / metabolism. Cauda Equina / pathology. Cell Transformation, Neoplastic / genetics. Cell Transformation, Neoplastic / metabolism. Cell Transformation, Neoplastic / pathology. Child. Female. Gene Expression Regulation, Neoplastic. Humans. Leiomyosarcoma / metabolism. Leiomyosarcoma / pathology. Male. Melanoma / metabolism. Melanoma / pathology. Middle Aged. Nestin. Neurilemmoma / metabolism. Neurilemmoma / pathology. Rhabdomyosarcoma / metabolism. Rhabdomyosarcoma / pathology. Sarcoma / metabolism. Sarcoma / pathology. Schwann Cells / metabolism. Schwann Cells / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17300669.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Intermediate Filament Proteins; 0 / NES protein, human; 0 / Nerve Tissue Proteins; 0 / Nestin
  •  go-up   go-down


20. Gudena V, Verma N, Post G, Kizziah M, Fenning R, Montero AJ: Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review. Cancer Biol Ther; 2008 Jun;7(6):810-3
Hazardous Substances Data Bank. NICOTINAMIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic chest wall malignant schwannoma responding to sorafenib: case report and literature review.
  • Malignant schwannomas or malignant peripheral nerve sheath tumors (MPNST) represent approximately 10% of all soft tissue sarcomas.
  • Metastatic disease from chest wall MPNST is very rare.
  • We present a case of a major clinical response to the tyrosine kinase inhibitor (TKI) sorafenib in a patient with metastatic MPNST.
  • A 42-year-old female with a prior history of neurofibromas developed MPNST, which later metastasized to the lungs and brain.
  • MPNST show high levels of Ras activity and hence these tumors are promising targets for TKIs.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Benzenesulfonates / therapeutic use. Nerve Sheath Neoplasms / diagnosis. Nerve Sheath Neoplasms / drug therapy. Neurilemmoma / diagnosis. Neurilemmoma / drug therapy. Pyridines / therapeutic use. Thoracic Wall / pathology
  • [MeSH-minor] Adult. Brain Neoplasms / drug therapy. Brain Neoplasms / secondary. Female. Humans. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Magnetic Resonance Imaging. Neoplasm Metastasis. Niacinamide / analogs & derivatives. Phenylurea Compounds. Protein Kinase Inhibitors / therapeutic use. Radiography, Thoracic. Treatment Outcome

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18376142.001).
  • [ISSN] 1555-8576
  • [Journal-full-title] Cancer biology & therapy
  • [ISO-abbreviation] Cancer Biol. Ther.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzenesulfonates; 0 / Phenylurea Compounds; 0 / Protein Kinase Inhibitors; 0 / Pyridines; 25X51I8RD4 / Niacinamide; 9ZOQ3TZI87 / sorafenib
  •  go-up   go-down


21. Thoennissen NH, Schliemann C, Brunnberg U, Schmidt E, Staebler A, Stegger L, Bremer C, Schleicher C, Mesters RM, Müller-Tidow C, Berdel WE: Chemotherapy in metastatic malignant triton tumor: report on two cases. Oncol Rep; 2007 Oct;18(4):763-7
MedlinePlus Health Information. consumer health - Uterine Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chemotherapy in metastatic malignant triton tumor: report on two cases.
  • Malignant triton tumor (MTT) is a rare, highly malignant nerve sheath tumor with rhabdomyoblastic differentiation.
  • [MeSH-major] Cecal Neoplasms / therapy. Ileal Neoplasms / therapy. Liver Neoplasms / therapy. Neurilemmoma / therapy. Ovarian Neoplasms / drug therapy. Uterine Neoplasms / therapy
  • [MeSH-minor] Adult. Antineoplastic Agents / therapeutic use. Chemotherapy, Adjuvant. Combined Modality Therapy. Female. Fluorodeoxyglucose F18. Humans. Male. Neoadjuvant Therapy. Neurofibromatosis 1 / pathology. Positron-Emission Tomography. Radiopharmaceuticals. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17786333.001).
  • [ISSN] 1021-335X
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


22. Sengöz A, Taşdemiroğlu E, Togay H: Is clear cell sarcoma a malignant form of psammomatous melanotic schwannoma? Case report. Neurosurg Focus; 2006;21(6):E11
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is clear cell sarcoma a malignant form of psammomatous melanotic schwannoma? Case report.
  • The authors present a case of clear cell sarcoma (CCS) in which the tumor originated in the S-1 nerve root and had been previously diagnosed as psammomatous melanotic schwannoma (PMS).
  • This is the third case of a spinal nerve root origin for CCS reported in the English-language literature.
  • The similar histogenesis of CCS and malignant melanoma supports the hypothesis that biological agents or immunotherapy are potentially important areas of investigation.
  • The border of the resection was extended 1 cm distal to the tumor margin.
  • The new histopathological diagnosis was CCS (malignant melanoma of soft tissue).
  • A CCS originating from peripheral nerves is quite rare.
  • [MeSH-major] Neurilemmoma / classification. Peripheral Nervous System Neoplasms / classification. Sarcoma, Clear Cell / classification. Spinal Nerve Roots / pathology
  • [MeSH-minor] Adolescent. Adult. Antigens, Neoplasm. Biomarkers, Tumor / analysis. Breast Neoplasms. Diagnosis, Differential. Diagnostic Errors. Female. Fibroadenoma. Humans. Keratins / analysis. Male. Melanins / analysis. Melanoma-Specific Antigens. Neoplasm Invasiveness. Neoplasm Proteins / analysis. Neoplasm Recurrence, Local. Neoplasms, Multiple Primary. Neoplastic Syndromes, Hereditary / diagnosis. Neoplastic Syndromes, Hereditary / genetics. Nerve Sheath Neoplasms / pathology. Pigmentation Disorders / diagnosis. Pigmentation Disorders / genetics. Prognosis. S100 Proteins / analysis. Sacrococcygeal Region. Syndrome. Vimentin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17341045.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Melanins; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / S100 Proteins; 0 / Vimentin; 68238-35-7 / Keratins
  • [Number-of-references] 17
  •  go-up   go-down


23. Marton E, Feletti A, Orvieto E, Longatti P: Dumbbell-shaped C-2 psammomatous melanotic malignant schwannoma. Case report and review of the literature. J Neurosurg Spine; 2007 Jun;6(6):591-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dumbbell-shaped C-2 psammomatous melanotic malignant schwannoma. Case report and review of the literature.
  • The authors present the case of a dumbbell-shaped malignant psammomatous melanotic schwannoma of the upper cervical spine involving the C-2 sensory root.
  • The family of the patient had a history of other malignant stromal tumors, without the Carney complex genetic pattern.
  • Histopathological examination of the lesion revealed it to be a malignant psammomatous melanotic schwannoma.
  • The cerebrospinal MR image of the patient obtained at the 12-month follow-up examination demonstrated the presence of tumor progression into the subarachnoid space at the C-3 level.
  • The strong malignancy potential of the lesion must be considered in the future management of the patient, especially due to the presence in the family of other stromal tumors such as gastrointestinal-stromal tumors and malignant melanomas.
  • The authors review all the literature concerning melanotic schwannomas and report 105 cases of melanotic schwannoma that were not related to the Carney complex.
  • The particular focus of their review is on the characteristics of the malignant progression of melanotic schwannoma, such as local recurrences, metastasis, and survival rate.
  • [MeSH-major] Cervical Vertebrae. Neurilemmoma / diagnosis. Spinal Neoplasms / diagnosis. Spinal Nerve Roots / pathology
  • [MeSH-minor] Adult. Female. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Neurosurgical Procedures

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17561752.001).
  • [ISSN] 1547-5654
  • [Journal-full-title] Journal of neurosurgery. Spine
  • [ISO-abbreviation] J Neurosurg Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 80
  •  go-up   go-down


24. Kubo O, Chernov M, Izawa M, Hayashi M, Muragaki Y, Maruyama T, Hori T, Takakura K: Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation? Minim Invasive Neurosurg; 2005 Dec;48(6):334-9
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation?
  • Malignant transformation of benign neoplasm after radiosurgery is usually diagnosed based on the initial presence of benign tumor, its exposure to ionizing radiation, elapsed time from radiation exposure to malignant progression, and different histological characteristics or growth rate of the regrowing tumor comparing with those originally treated.
  • Three presented cases fulfilled these diagnostic criteria; however, it seems that progression of the tumors (schwannoma, meningioma, chordoma) resulted from the natural course of the disease, rather than represented side effects of gamma knife radiosurgery.
  • Evaluation of the proliferative potential of the benign neoplasm before radiosurgical treatment either directly, if tumor sampling is available, or indirectly, by calculation of the tumor growth rate and/or analysis of the data of the metabolic imaging (PET, MRS) is important for identification of "aggressive" subtypes, precise prediction of prognosis, and confirmation of the radiation-induced malignant transformation in cases of tumor regrowth.
  • [MeSH-major] Brain Neoplasms / surgery. Cell Transformation, Neoplastic / radiation effects. Chordoma / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Neoplasms, Radiation-Induced / physiopathology. Neurilemmoma / surgery. Radiosurgery / adverse effects
  • [MeSH-minor] Adult. Brain Diseases / surgery. Cell Proliferation. Female. Humans. Male. Middle Aged. Prognosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16432782.001).
  • [ISSN] 0946-7211
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  •  go-up   go-down


25. Yang BB, Jiang H, Chang HY: Malignant triton tumour of the parapharyngeal space: a case arising from the cervical sympathetic nerve. J Laryngol Otol; 2008 May;122(5):531-4
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant triton tumour of the parapharyngeal space: a case arising from the cervical sympathetic nerve.
  • BACKGROUND: Malignant triton tumour is a relatively rare, aggressive sarcoma comprising both malignant schwannoma cells and malignant rhabdomyoblasts.
  • Malignant triton tumour of the parapharyngeal space is exceptionally rare, with only one case being described in the literature.
  • Malignant triton tumour of the cervical sympathetic nerve has not previously been reported.
  • METHODS: We report a case involving the parapharyngeal space and arising from the cervical sympathetic nerve, and we review the management and outcome of the previous case reported in this rare location.
  • Owing to this specific localisation, adjuvant therapy in addition to complete resection may be important in the treatment of malignant triton tumour in this rare location.
  • [MeSH-major] Neurilemmoma / pathology. Pharyngeal Neoplasms / pathology. Sarcoma / pathology. Sympathetic Nervous System / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Fatal Outcome. Humans. Magnetic Resonance Imaging. Male. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17498335.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


26. Fisher BJ, Dennis KE: Malignant epithelioid cranial nerve sheath tumor: case report of a radiation response. J Neurooncol; 2006 Jun;78(2):173-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant epithelioid cranial nerve sheath tumor: case report of a radiation response.
  • Malignant epithelioid nerve sheath tumors (MESs) especially those involving intracranial cranial nerves are rare and thought to be radioresistant.
  • A 41-year-old man with progressive left facial weakness underwent an MRI that disclosed an enhancing lesion involving both V3 cranial nerve and the distal VIIth nerve.
  • Biopsy confirmed a malignant epithelioid schwannoma.
  • The tumor was resected but residual tumor was present at the cut end of the infraorbital nerve, within the oral cavity and at the brainstem.
  • Tumor was controlled for 38 months and then radiographic recurrence was resected from the infratemporal fossa outside the irradiated field.A new primary MES tumor developed at 69 months at the C1/C2 root levels at the lower edge of the previously irradiated field.
  • It was subtotally resected but by 77 months residual tumor had grown inferiorly down to C5 so this area was re-irradiated with a complicated 7-field approach to spare spinal cord.
  • Initially the tumor responded but ultimately progressed posteriorly where radiation dose was limited by spinal cord tolerance.
  • New involvement of the Xth cranial nerve was noted.
  • The long-term control of the original tumor despite positive margins argues for the use of radiotherapy in the treatment of these tumors.
  • [MeSH-major] Cranial Nerve Neoplasms / radiotherapy. Facial Nerve Diseases / radiotherapy. Nerve Sheath Neoplasms / radiotherapy. Neurilemmoma / radiotherapy. Trigeminal Nerve Diseases / radiotherapy
  • [MeSH-minor] Adult. Facial Nerve / pathology. Facial Nerve / surgery. Humans. Male. Radiotherapy Dosage. Treatment Outcome. Trigeminal Nerve / pathology. Trigeminal Nerve / surgery

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16557352.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


27. Ziadi A, Saliba I: Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review. Auris Nasus Larynx; 2010 Oct;37(5):539-45
Genetic Alliance. consumer health - Malignant peripheral nerve sheath tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
  • OBJECTIVES: The incidence of malignant peripheral nerve sheath tumor (MPNST) is approximately 0.001%.
  • (1) to review all cases of intracranial MPNST described in the literature, (2) to highlight the suspicion of intracranial MPNST, (3) to identify the gross pathology, the histopathology, the immunohistochemistry, (4) to discuss the differential diagnosis, the treatment, the recurrence rate, the follow-up, the incidence of metastasis and the prognosis.
  • We used the following Keywords: "malignant peripheral nerve sheath tumor", "cranial nerve", "neurosarcoma", "malignant schwannoma", "neurofibroma", "malignant neurofibroma" and "nerve tumor".
  • We considered cases where MPNST involved an intracranial cranial nerve.
  • RESULTS: We identified 32 cases of cranial MPNST including our case.
  • Most cases are developed sporadically (50%), 31% arise from a malignant transformation of schwannoma and 19% from a neurofibroma.
  • The cranial nerve VIII is the most involved (15/32), followed by the Vth (10/32) and the VIIth (5/32).
  • MPNST will strongly express protein S-100 and collagen IV-laminin.
  • 13 cases were treated with radiotherapy for tumor recurrence and metastasis.
  • CONCLUSION: MPNST of cranial nerves are very rare.
  • In neurofibroma, even though MPNST is mainly associated to type 1, we should keep in mind its association to NF2.
  • Inaccessibility of cranial MPNST may explain the subtotal resection and thus the poor prognosis.
  • [MeSH-major] Cranial Nerve Neoplasms / diagnosis. Nerve Sheath Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Cell Transformation, Neoplastic / pathology. Child. Child, Preschool. Diagnosis, Differential. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / mortality. Neoplasm Recurrence, Local / pathology. Neurilemmoma / diagnosis. Neurilemmoma / pathology. Neurilemmoma / radiotherapy. Neurilemmoma / surgery. Neurofibroma / diagnosis. Neurofibroma / pathology. Neurofibroma / radiotherapy. Neurofibroma / surgery. Neurofibromatosis 1 / diagnosis. Neurofibromatosis 1 / pathology. Neurofibromatosis 1 / radiotherapy. Neurofibromatosis 1 / surgery. Neurofibromatosis 2 / diagnosis. Neurofibromatosis 2 / pathology. Neurofibromatosis 2 / radiotherapy. Neurofibromatosis 2 / surgery. Radiotherapy, Adjuvant. Spinal Neoplasms / mortality. Spinal Neoplasms / pathology. Spinal Neoplasms / secondary. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20399579.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 35
  •  go-up   go-down


28. Ghosh A, Talwar OP, Pradhan SV: Tumour and tumour-like conditions of peripheral nerve origin: ten years' experience. Kathmandu Univ Med J (KUMJ); 2010 Jan-Mar;8(29):97-101
Genetic Alliance. consumer health - TEN.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumour and tumour-like conditions of peripheral nerve origin: ten years' experience.
  • BACKGROUND: There are four major lesions which may arise in the peripheral nerve, namely neuroma, schwannoma, neurofibroma and malignant peripheral nerve sheath tumor.
  • OBJECTIVE: In the present study we look into the spectrum of peripheral neural tumors including their age distribution site distribution and histopathology.
  • All histopathologically diagnosed cases of primary lesions of peripheral nerve during the period Jan 2000 to Nov 2009 were reviewed and the data were analysed.
  • RESULT: A total of 114 cases of peripheral neural lesions were reported in the same period.
  • Total number of nonmalignant cases was 106 (93%) while malignant cases were 8 (7%).
  • Among the nonmalignant cases neurofibroma was the commonest (51 cases, 45% of all) closely followed by schwannoma (39 cases, 34% of all).
  • Among the schwannoma cases 4 were diagnosed as ancient schwannoma with presence of bizarre cells with hyperchromatic nuclei.
  • The commonest site involved for both schwannoma and neurofibroma was scalp-face-neck followed by back.
  • The age range for schwannoma was 16 to 75 years whereas the same for the neurofibroma cases was 2 to 82 years.
  • MPNST cases were seen in the age range of 40 to 72 with 3 cases in upper extremity, 3 in lower extremity and 1 each in lip and cheek.
  • CONCLUSION: The majority of the tumor are benign and the commonest benign tumor was neurofibroma of sporadic type, closely followed by schwannoma.
  • [MeSH-major] Nerve Sheath Neoplasms / epidemiology. Neurilemmoma / epidemiology. Neurofibroma / epidemiology. Neuroma / epidemiology. Peripheral Nervous System Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Humans. Male. Middle Aged. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21209517.001).
  • [ISSN] 1812-2078
  • [Journal-full-title] Kathmandu University medical journal (KUMJ)
  • [ISO-abbreviation] Kathmandu Univ Med J (KUMJ)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


29. Bendix N, Wolf C, Gruber H, Bodner G: [Pictorial essay: Ultrasound of tumours and tumour-like lesions of peripheral nerves]. Ultraschall Med; 2005 Aug;26(4):318-24
MedlinePlus Health Information. consumer health - Peripheral Nerve Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pictorial essay: Ultrasound of tumours and tumour-like lesions of peripheral nerves].
  • High-resolution ultrasound is an excellent diagnostic modality for visualising peripheral nerves and differentiate tumours of the peripheral nerve.
  • With high-frequency transducers (5-15 MHz), peripheral nerves can be visualised, the hypoechoic nerve fascicles, the surrounding tissue and tumourous lesions including the relation to their nerve of origin can be evaluated.
  • By using colour Doppler sonography (CDS), it is possible to detect and assess vascularisation of tumours of the nerve.
  • We present sonographic features of common and uncommon benign and malignant tumours of the peripheral nerve.
  • [MeSH-major] Peripheral Nerve Injuries. Peripheral Nervous System Diseases / ultrasonography. Peripheral Nervous System Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Neurilemmoma / ultrasonography. Neurofibroma / ultrasonography. Neuroma / ultrasonography. Peripheral Nerves / ultrasonography. Reproducibility of Results. Sensitivity and Specificity

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16123927.001).
  • [ISSN] 0172-4614
  • [Journal-full-title] Ultraschall in der Medizin (Stuttgart, Germany : 1980)
  • [ISO-abbreviation] Ultraschall Med
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


30. Uranues S, Grossman D, Ludwig L, Bergamaschi R: Laparoscopic partial splenectomy. Surg Endosc; 2007 Jan;21(1):57-60
MedlinePlus Health Information. consumer health - Spleen Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Data on consecutive patients presenting with localized benign or malignant disease of the spleen were included in a prospective database.
  • The indications included splenomegaly of unknown origin, splenic cysts, benign tumors (hamartoma), and metastasis from ovarian carcinoma and schwannoma.
  • CONCLUSION: Laparoscopic partial splenectomy is safe for patients with localized benign or malignant disease of the spleen.
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoma / secondary. Carcinoma / surgery. Cysts / surgery. Databases, Factual. Female. Hamartoma / surgery. Humans. Length of Stay. Male. Middle Aged. Neurilemmoma / secondary. Neurilemmoma / surgery. Ovarian Neoplasms / secondary. Ovarian Neoplasms / surgery. Pleural Effusion / etiology. Splenic Neoplasms / surgery. Splenomegaly / surgery. Time Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Clin North Am. 2005 Feb;85(1):75-90, ix [15619530.001]
  • [Cites] J Surg Res. 1980 Jan;28(1):14-7 [7359904.001]
  • [Cites] Br J Haematol. 1999 Oct;107(1):55-68 [10520025.001]
  • [Cites] Presse Med. 1991 Dec 21-28;20(44):2263 [1838167.001]
  • [Cites] Am J Surg. 1994 Jul;168(1):49-53 [8024098.001]
  • [Cites] Surg Endosc. 2004 Nov;18(11):1620-4 [15931477.001]
  • [Cites] Surg Endosc. 1992 Jul-Aug;6(4):183-5 [1387735.001]
  • [Cites] Ann Surg. 1998 Jul;228(1):35-9 [9671064.001]
  • [Cites] Surg Laparosc Endosc. 1995 Apr;5(2):133-6 [7773460.001]
  • [Cites] World J Surg. 2001 Nov;25(11):1405-7 [11760743.001]
  • [Cites] Surg Clin North Am. 2005 Feb;85(1):1-18, vii [15619524.001]
  • [Cites] Perspect Pediatr Pathol. 1973;1:285-311 [4596312.001]
  • (PMID = 17031738.001).
  • [ISSN] 1432-2218
  • [Journal-full-title] Surgical endoscopy
  • [ISO-abbreviation] Surg Endosc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


31. Rong BG, Chen WL, Ding YP, Xie G, Chen Y, Wang TD: [Surgical approaches to the skull base neoplasms]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr;40(4):291-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eleven surgical approaches including midfacial degloving, frontal coronal discission, nasal eversion, maxillary swing, partial maxillary resection, total resection of orbit, mandibular swing, combination of front, temple, preauricular, post aureum, neck, and transoral approaches were used to resect the tumor which involved fossae pterygopalatine, paranasal sinuses, nasopharynx, antero, meso and posterobasilar region, lobi frontalis and lobi temporalis of cerebrum.
  • In 29 patients with benign tumor including 11 cases of meningioma, 3 cases of chondroma, 1 case of hemangio-meningioma, 1 case of cavernous hemangioma, 2 cases of osteodysplasia fibromas, 9 cases of neurofibroma, 1 case of glomus jugular tumor, 1 case of neurilemmoma, 19 have survived over 5 years and the longest one has survived over 8 years.
  • For 50 patients with malignant tumor including 3 cases of well-differentiated squamous cell carcinoma, 17 cases of moderately differentiated squamous cell carcinoma, 11 cases of poorly differentiated squamous cell carcinoma, 1 case of undifferentiated carcinoma, 2 cases of chondrosarcoma, 5 cases of canceration of papilloma, 2 cases of adenocarcinoma, 1 case of esthesioneuroblastoma, 2 cases of malignant fibrohistiocytoma, 1 case of fibrosarcoma, 2 cases of malignant mixed tumour, 3 cases of sarcoma survival rates of 3 and 5 years were 59.2% (29/49), 38.5% (10/26) respectively.
  • CONCLUSION: In order to resect the tumor completely and reduce the complication and malformation as far as possible, different surgical approaches must be designed according to the pathological changes characters and involved area,and the surgeon should select the shortest approach, avoid to damage the important neurovascular structure, and resect the tumor through the natural anatomy space by the shelter incision.
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16008265.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


32. Miyamoto J, Tatsuzawa K, Owada K, Kawabe T, Sasajima H, Mineura K: Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors. Neurol Med Chir (Tokyo); 2008;48(11):495-9; discussion 499

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twelve patients with 13 orbital tumors underwent [18F]FDG PET followed by biopsy or tumor removal via a transcranial approach.
  • The accumulation ratio between the tumor and the contralateral normal tissue (T/N ratio) was calculated for 10 of the 13 lesions.
  • The T/N ratio in benign lesions was compared with that in malignant tumors.
  • Histological examination identified 7 lesions as malignant: anaplastic astrocytoma of the optic nerve in 1 patient, which recurred as glioblastoma of the optic nerve, malignant lymphoma of mucosa-associated lymphoid tissue type in 1 patient, malignant melanoma in 1 patient, adenoid cystic carcinoma in 2 patients, and adenocarcinoma (unknown origin) in 1 patient.
  • The T/N ratio was 1.06 +/- 0.03 (mean +/- standard deviation) in benign tumors, and significantly higher at 1.81 +/- 0.27 in malignant tumors (p = 0.0027).
  • [18F]FDG PET can determine the malignancy of orbital tumors, but cannot distinguish malignant tumor from inflammatory disease such as pseudotumor.
  • [MeSH-major] Optic Nerve Neoplasms / radionuclide imaging. Orbital Neoplasms / radionuclide imaging. Positron-Emission Tomography
  • [MeSH-minor] Adenocarcinoma / radionuclide imaging. Adolescent. Adult. Aged. Astrocytoma / radionuclide imaging. Carcinoma, Adenoid Cystic / radionuclide imaging. Diagnosis, Differential. Female. Fluorine Radioisotopes. Fluorodeoxyglucose F18. Glioblastoma / radionuclide imaging. Hemangioma, Cavernous, Central Nervous System / radionuclide imaging. Humans. Lymphoma, B-Cell, Marginal Zone / radionuclide imaging. Male. Melanoma / radionuclide imaging. Middle Aged. Neurilemmoma / radionuclide imaging. Orbital Pseudotumor / radionuclide imaging. Radiopharmaceuticals. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19029776.001).
  • [ISSN] 1349-8029
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Case Reports; Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


33. Kaehler KC, Russo PA, Katenkamp D, Kreusch T, Neuber K, Schwarz T, Hauschild A: Melanocytic schwannoma of the cutaneous and subcutaneous tissues: three cases and a review of the literature. Melanoma Res; 2008 Dec;18(6):438-42
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanocytic schwannoma of the cutaneous and subcutaneous tissues: three cases and a review of the literature.
  • Melanocytic schwannoma is a rare soft-tissue tumor, which arises most commonly in the paraspinal sympathetic chain.
  • To date, only 17 cases of a cutaneous and subcutaneous melanocytic schwannoma have been reported.
  • Three cases of cutaneous melanocytic schwannoma, diagnosed in our institution are reported.
  • For further literature overview we performed a search on Medline using the terms 'melanocytic schwannoma' or 'melanotic schwannoma' or 'Carney complex' combined with 'skin' or 'cutaneous', for the period 1970-2007.
  • Seventeen patients were described to have melanocytic schwannoma of the skin or subcutaneous tissues.
  • In contrast, none of the reported cases of cutaneous or subcutaneous melanocytic schwannomas was characterized by a malignant course.
  • The differential diagnosis, especially with regard to malignant melanoma, is made by histology and by its clinical course, which differs from melanoma in its tendency to recur at the site of excision and slow rate of growth.
  • Commonly misdiagnosed as melanoma, this tumor reveals insights into the origin of both melanocytes and Schwann cells.
  • It is likely that the biological bases for melanoma and melanocytic schwannoma differ.
  • It is necessary to differentiate this tumor from melanoma because of the differing prognosis and the association of melanocytic schwannoma with the Carney complex.
  • [MeSH-major] Melanoma / diagnosis. Neurilemmoma / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Subcutaneous Tissue / pathology

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19011514.001).
  • [ISSN] 1473-5636
  • [Journal-full-title] Melanoma research
  • [ISO-abbreviation] Melanoma Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 28
  •  go-up   go-down


34. Zadeh G, Buckle C, Shannon P, Massicotte EM, Wong S, Guha A: Radiation induced peripheral nerve tumors: case series and review of the literature. J Neurooncol; 2007 Jun;83(2):205-12
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation induced peripheral nerve tumors: case series and review of the literature.
  • PURPOSE: Radiation induced peripheral nerve tumors (PNT) are a rare but known complication of radiotherapy.
  • RESULTS: Patient's ranged in age from 18 months to 49 years at the time of their original diagnosis, with radiation doses to the primary tumor ranging from 24 to 40 Gy with post radiation intervals from 10 to 50 years.
  • While the pathology of PNT induced transformation is still poorly understood, experiments and pathology are congruent on the possibility of malignant transformation, especially for the "atypical neurofibroma".
  • [MeSH-major] Neoplasms, Radiation-Induced / etiology. Neurilemmoma / etiology. Neurofibroma / etiology. Peripheral Nervous System Neoplasms / etiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasms / radiotherapy. Peripheral Nerves / radiation effects. Radiotherapy / adverse effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17206473.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 21
  •  go-up   go-down


35. Azarpira N, Torabineghad S, Sepidbakht S, Rakei M, Bagheri MH: Cytologic findings in pigmented melanotic schwannoma: a case report. Acta Cytol; 2009 Jan-Feb;53(1):113-5
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytologic findings in pigmented melanotic schwannoma: a case report.
  • BACKGROUND: Psammomatous melanotic schwannoma (PMS) is a rare pigmented neural tumor most commonly occurring in the paraspinal region.
  • This rare tumor can cause diagnostic difficulties in imprint cytology due to cellular details masked by heavy melanin pigments.
  • Radiologic studies showed a 3.5-cm epidural mass in the region of the left L2 nerve root.
  • Imprint smears from the biopsied tissue fragment revealed mainly epithelioid cells with prominent nucleoli and variable amounts of cytoplasmic brown pigment, indicating a pigmented tumor with neuronal origin PMS, which was confirmed by histologic and immunohistochemical studies of the resected tumor.
  • CONCLUSION: PMS is a rare entity, and it is important to differentiate PMS from other pigmented tumors in the spinal canal, such as melanocytoma and malignant melanoma.
  • [MeSH-major] Neurilemmoma / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Melanins. Pigmentation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19248566.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Melanins
  •  go-up   go-down


36. Hamada K, Ueda T, Higuchi I, Inoue A, Tamai N, Myoi A, Tomita Y, Aozasa K, Yoshikawa H, Hatazawa J: Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging. Skeletal Radiol; 2005 Jan;34(1):52-7
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging.
  • We present two cases of peripheral nerve schwannoma which showed an increased accumulation of 2-deoxy-[(18)F] fluoro-D-glucose (FDG) in the tumors on positron emission tomography (PET) imaging acquired at both 1 h (early phase) and 2 h (delayed phase) after FDG injection.
  • We set the maximum standardized uptake value (SUV max) with a cut-off point of 3.0 to distinguish benign and malignant lesions.
  • Although the mechanism responsible for the increased FDG uptake in benign schwannomas remains unknown, we discuss our findings in the context of tumor cellularity and briefly review other studies on the subject.
  • [MeSH-major] Fluorodeoxyglucose F18. Neurilemmoma / diagnostic imaging. Peripheral Nervous System Neoplasms / diagnostic imaging. Positron-Emission Tomography / methods. Radiopharmaceuticals
  • [MeSH-minor] Adult. Female. Follow-Up Studies. Head and Neck Neoplasms / diagnostic imaging. Humans. Muscle Neoplasms / diagnostic imaging. Retroperitoneal Neoplasms / diagnostic imaging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Nucl Med. 1999 Jun;26(6):599-605 [10369945.001]
  • [Cites] AJR Am J Roentgenol. 2004 Apr;182(4):971-4 [15039173.001]
  • [Cites] J Peripher Nerv Syst. 1998;3(1):28-36 [10959235.001]
  • [Cites] Nucl Med Biol. 1998 Oct;25(7):589-92 [9804038.001]
  • [Cites] J Orthop Surg (Hong Kong). 2002 Jun;10(1):77-84 [12401926.001]
  • [Cites] Eur J Nucl Med. 1999 Jan;26(1):22-30 [9933658.001]
  • [Cites] J Nucl Med. 1991 Aug;32(8):1508-12 [1869970.001]
  • [Cites] Eur J Nucl Med. 2000 Oct;27(10 ):1509-17 [11083540.001]
  • [Cites] Skeletal Radiol. 2000 Sep;29(9):538-42 [11000301.001]
  • [Cites] Urology. 2003 Dec;62(6):993-7 [14665342.001]
  • [Cites] Eur J Nucl Med. 2001 Oct;28(10 ):1541-51 [11685498.001]
  • [Cites] J Nucl Med. 1988 Feb;29(2):181-6 [2831318.001]
  • [Cites] Clin Radiol. 1997 Jan;52(1):8-17 [9022574.001]
  • [Cites] J Nucl Med. 1991 Apr;32(4):623-48; discussion 649-50 [2013803.001]
  • [Cites] Skeletal Radiol. 2003 Mar;32(3):133-8 [12605276.001]
  • [Cites] J Orthop Sci. 2003;8(3):435-41 [12768492.001]
  • [Cites] Skeletal Radiol. 1999 Apr;28(4):183-8 [10384987.001]
  • [Cites] J Comput Assist Tomogr. 1992 May-Jun;16(3):448-53 [1317391.001]
  • [Cites] Eur J Nucl Med. 2001 Jun;28(6):696-703 [11440029.001]
  • [Cites] AJR Am J Roentgenol. 2004 Feb;182(2):534-5 [14736701.001]
  • [Cites] Acta Radiol. 1994 May;35(3):282-6 [8192968.001]
  • (PMID = 15480645.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


37. Agarwal K, Agarwal C, Agarwal M, Harbhajanka A: Plexiform schwannoma of scalp: a case report with brief review of literature. Indian J Pathol Microbiol; 2007 Oct;50(4):797-9
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for plexiform schwannoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Plexiform schwannoma of scalp: a case report with brief review of literature.
  • Plexiform schwannoma is a morphologically distinct and rare variant of schwannoma.
  • It is a benign tumor and malignant transformation has not been reported.
  • We are presenting a case of plexiform schwannoma occurring on scalp and measuring 8cm in size because of its rarity and unusual size.
  • [MeSH-major] Neurilemmoma / diagnosis. Neurilemmoma / pathology. Scalp / pathology
  • [MeSH-minor] Adult. Biopsy. Humans. Male

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18306559.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Number-of-references] 15
  •  go-up   go-down


38. Inokuchi T, Takiuchi H, Moriwaki Y, Ka T, Takahashi S, Tsutsumi Z, Shima H, Hirota S, Yamamoto T: Retroperitoneal ancient schwannoma presenting as an adrenal incidentaloma: CT and MR findings. Magn Reson Imaging; 2006 Dec;24(10):1389-93
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal ancient schwannoma presenting as an adrenal incidentaloma: CT and MR findings.
  • A laparoscopic adrenalectomy was performed under the suspicion of a malignant tumor, such as a malignant fibrous histiocytoma.
  • Pathologic findings indicated a retroperitoneal ancient schwannoma of two histologic types: Antoni A and Antoni B.
  • We considered that elucidation of the characteristic features of a schwannoma would provide helpful preoperative information for diagnosis.
  • [MeSH-major] Magnetic Resonance Imaging. Neurilemmoma / pathology. Retroperitoneal Neoplasms / pathology. Tomography, X-Ray Computed
  • [MeSH-minor] Abdomen / ultrasonography. Adrenal Gland Neoplasms / pathology. Adrenal Gland Neoplasms / radiography. Adrenal Gland Neoplasms / ultrasonography. Adult. Diagnosis, Differential. Female. Humans

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17145411.001).
  • [ISSN] 0730-725X
  • [Journal-full-title] Magnetic resonance imaging
  • [ISO-abbreviation] Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Tagore KR, Krishna R, Charyulu PA, Latha PP: A rare case of cellular schwannoma in the pharynx. Indian J Pathol Microbiol; 2007 Oct;50(4):835-7
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare case of cellular schwannoma in the pharynx.
  • These tumors histologically mimic malignant peripheral nerve sheath tumors because of their growth pattern, high cellularity and mitotic activity, but they are relatively benign tumors with a tendency to recur but do not metastasize.
  • [MeSH-major] Neurilemmoma / diagnosis. Neurilemmoma / pathology. Pharyngeal Neoplasms / diagnosis. Pharyngeal Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male. Neck / radiography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18306575.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


40. Mey KH, Buchwald C, Daugaard S, Prause JU: Sinonasal schwannoma--a clinicopathological analysis of five rare cases. Rhinology; 2006 Mar;44(1):46-52
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sinonasal schwannoma--a clinicopathological analysis of five rare cases.
  • Schwannoma of the nasal cavity or the sinuses is a rare condition.
  • Four cases were benign; however, one case of melanotic schwannoma, exhibited malignant transformation.
  • All tumours were treated surgically; only the malignant case received adjuvant radiotherapy.
  • The benign cases have so far shown good prognosis without recurrences; however, in the case of the melanotic schwannoma a fatal malignant transformation was seen 13 years after initial diagnosis.
  • [MeSH-major] Neurilemmoma / pathology. Nose Neoplasms / pathology. Paranasal Sinus Neoplasms / pathology
  • [MeSH-minor] Adult. Aged, 80 and over. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16550950.001).
  • [ISSN] 0300-0729
  • [Journal-full-title] Rhinology
  • [ISO-abbreviation] Rhinology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


41. Levi AD, Ross AL, Cuartas E, Qadir R, Temple HT: The surgical management of symptomatic peripheral nerve sheath tumors. Neurosurgery; 2010 Apr;66(4):833-40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The surgical management of symptomatic peripheral nerve sheath tumors.
  • OBJECTIVE: To determine the clinical presentation and morbidity of the surgical management of peripheral nerve sheath tumors (PNSTs).
  • RESULTS: There were a total of 140 cases, including 87 schwannomas, 34 neurofibromas, and 19 malignant peripheral nerve sheath tumors (MPNSTs).
  • Tumor size was the best predictor of adverse outcome, as all MPNST mortalities occurred in patients with a tumor size of more than 7 cm.
  • [MeSH-major] Nerve Sheath Neoplasms / surgery. Neurilemmoma / surgery. Neurofibroma / surgery. Neurosurgery / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Retrospective Studies. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20190660.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Li Q, Gao C, Juzi JT, Hao X: Analysis of 82 cases of retroperitoneal schwannoma. ANZ J Surg; 2007 Apr;77(4):237-40
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of 82 cases of retroperitoneal schwannoma.
  • BACKGROUND: The aim of the study was to improve the diagnosis and treatment of retroperitoneal schwannoma by analysing clinical manifestations and postoperative course of this rare disease.
  • METHODS: A retrospective analysis of 82 patients with retroperitoneal schwannoma between January 1951 and September 2004 was carried out.
  • Pathological results showed 81 (98.8%) were benign schwannoma and 1 (1.2%) was a malignant one.
  • One benign schwannoma recurred 3 years after the operation.
  • The patient with malignant schwannoma died 18 months after the operation because of metastasized disease.
  • Malignant schwannomas are insensitive to chemotherapy and radiation, resulting in poor prognosis.
  • [MeSH-major] Neurilemmoma / diagnosis. Neurilemmoma / surgery. Retroperitoneal Neoplasms / diagnosis. Retroperitoneal Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Diagnostic Imaging. Female. Humans. Infant. Male. Middle Aged. Neoplasm Recurrence, Local. Prognosis. Retrospective Studies. Survival Analysis. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17388825.001).
  • [ISSN] 1445-1433
  • [Journal-full-title] ANZ journal of surgery
  • [ISO-abbreviation] ANZ J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


43. Messing-Jünger AM, Riemenschneider MJ, Reifenberger G: A 21-year-old female with a third ventricular tumor. Brain Pathol; 2006 Jan;16(1):87-8, 93

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A 21-year-old female with a third ventricular tumor.
  • Intraoperatively, the tumor showed a close relationship to the choroid plexus of the third ventricle.
  • Histopathology revealed a benign schwannoma of World Health Organization grade I.
  • Most of these tumors were benign schwannomas, except for 2 cases of malignant peripheral nerve sheath tumors.
  • The tumor of our patient is the first reported schwannoma of the third ventricle.
  • Histologically, intraventricular schwannoma needs to be distinguished from other spindle cell tumors, in particular pilocytic astrocytoma and fibroblastic meningioma.
  • [MeSH-major] Cerebral Ventricle Neoplasms / pathology. Neurilemmoma / pathology. Neurilemmoma / surgery
  • [MeSH-minor] Adult. Brain / pathology. Female. Humans. Magnetic Resonance Imaging. Neurosurgical Procedures

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16612987.001).
  • [ISSN] 1015-6305
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Switzerland
  •  go-up   go-down


44. Bocciolini C, Dall'olio D, Cavazza S, Laudadio P: Schwannoma of cervical sympathetic chain: assessment and management. Acta Otorhinolaryngol Ital; 2005 Jun;25(3):191-4
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Schwannoma of cervical sympathetic chain: assessment and management.
  • Schwannoma arising from the cervical sympathetic chain is an uncommon benign nerve tumour.
  • This tumour most often presents as an asymptomatic solitary neck mass, with slow-growing and rare malignant degeneration.
  • The pathologic and radiological evaluations, treatment and postoperative complications of this neoplasm are discussed.
  • [MeSH-major] Ganglia, Sympathetic / pathology. Head and Neck Neoplasms / diagnosis. Head and Neck Neoplasms / surgery. Neurilemmoma / diagnosis. Neurilemmoma / surgery
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging. Male

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Surg. 2000 Jan;66(1):52-5 [10651348.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2000 Jan;109(1):48-51 [10651412.001]
  • [Cites] Acta Otolaryngol. 2002 Jun;122(4):435-7 [12126003.001]
  • [Cites] Otolaryngol Head Neck Surg. 2002 Jul;127(1):127-8 [12161744.001]
  • [Cites] Otolaryngol Head Neck Surg. 1997 Dec;117(6):S206-10 [9419150.001]
  • [Cites] Radiology. 1984 Mar;150(3):729-35 [6695075.001]
  • [Cites] J Otolaryngol. 1992 Jun;21(3):186-8 [1404569.001]
  • [Cites] Laryngoscope. 1996 Dec;106(12 Pt 1):1548-52 [8948621.001]
  • [Cites] J Laryngol Otol. 1997 May;111(5):493-5 [9205620.001]
  • [Cites] Br J Ophthalmol. 2003 Mar;87(3):366-7 [12598461.001]
  • (PMID = 16450776.001).
  • [ISSN] 0392-100X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 13
  • [Other-IDs] NLM/ PMC2639869
  •  go-up   go-down


45. Mosunjac MB, Johnston EI, Mosunjac MI: Fine-needle aspiration cytologic diagnosis of metastatic melanotic schwannoma: familial case of a mother and daughter with Carney's complex and literature review. Diagn Cytopathol; 2007 Feb;35(2):130-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine-needle aspiration cytologic diagnosis of metastatic melanotic schwannoma: familial case of a mother and daughter with Carney's complex and literature review.
  • Carney's complex is an autosomal dominant, multisystem tumorous disorder that includes myxomas, spotty skin pigmentation, endocrine tumors, and peripheral nerve tumors.
  • Here, we describe the first known familial case of a mother and daughter, both presenting with malignant, already metastatic, pigmented schwannomas initially diagnosed as metastatic melanoma by CT guided fine-needle aspiration.
  • Patients with highly pigmented, extra-cutaneous lesions that are clinically and pathologically suspicious for metastatic malignant melanoma, without known primary tumor, should be evaluated for possible Carney's complex.
  • Additional screening of family members should be recommended to exclude the presence of potentially malignant neoplasms, such as psammomatous melanotic schwannomas.
  • [MeSH-major] Melanins / metabolism. Myxoma / diagnosis. Neoplasms, Multiple Primary / diagnosis. Neurilemmoma / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Heart Neoplasms / genetics. Heart Neoplasms / pathology. Humans. Melanoma / diagnosis. Middle Aged. Nevus, Blue / diagnosis. Nevus, Blue / genetics. Nevus, Blue / pathology. Syndrome

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17230569.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Melanins
  •  go-up   go-down


46. Kandil E, Abdel Khalek M, Abdullah O, Dali D, Faruqui S, Khan A, Friedlander P, Jaffe BM, Crawford B: Primary peripheral nerve sheath tumors of the thyroid gland. Thyroid; 2010 Jun;20(6):583-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary peripheral nerve sheath tumors of the thyroid gland.
  • BACKGROUND: Primary peripheral nerve sheath tumors (PNSTs) of the thyroid gland are exceptionally rare tumors that usually present as asymptomatic neck nodules in adults.
  • SUMMARY: PNSTs of the thyroid can be classified into benign and malignant.
  • Only three cases of malignant PNSTs have been reported.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Male. Middle Aged. Nerve Sheath Neoplasms / pathology. Nerve Sheath Neoplasms / surgery. Neurilemmoma / pathology. Neurilemmoma / surgery. Neurofibroma / pathology

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20553194.001).
  • [ISSN] 1557-9077
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 26
  •  go-up   go-down


47. Bäck L, Heikkilä T, Passador-Santos F, Saat R, Leivo I, Mäkitie AA: Management of facial nerve schwannoma: A single institution experience. Acta Otolaryngol; 2010 Oct;130(10):1193-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of facial nerve schwannoma: A single institution experience.
  • CONCLUSION: Difficulties in diagnosis, conservative initial steps in the management algorithm and intraoperative risks for facial nerve (FN) injury are divisive features for this tumour entity.
  • One patient is currently under conservative follow-up for a parotid schwannoma (diagnosed with magnetic resonance imaging) with intact FN function.
  • No malignant schwannomas were encountered.
  • [MeSH-major] Cranial Nerve Neoplasms / surgery. Facial Nerve. Neurilemmoma / surgery. Neurosurgical Procedures / methods
  • [MeSH-minor] Adult. Aged. Biopsy, Fine-Needle. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Retrospective Studies. Tomography, X-Ray Computed. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20441526.001).
  • [ISSN] 1651-2251
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


48. Aguirre-Quezada DE, Martínez-Anda JJ, Aguilar-Ayala EL, Chávez-Macías L, Olvera-Rabiela JE: [Intracranial and intramedullary peripheral nerve sheath tumours. Case reports from 20 autopsies]. Rev Neurol; 2006 Aug 16-31;43(4):197-200
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial and intramedullary peripheral nerve sheath tumours. Case reports from 20 autopsies].
  • INTRODUCTION: Tumors arising from the sheath of peripheral nerves, both intracranial and intraspinal, are uncommon and are sometimes of difficult clinical diagnosis, especially when they occur in unusual sites.
  • Histological malignancy of this neoplasm is rare.
  • MATERIALS AND METHODS: The clinical and pathological findings of 20 autopsy cases of intracranial and intraspinal peripheral nerve tumors are analyzed.
  • RESULTS: 19 were schwannomas, 13 of the 8th cranial nerve (two associated with neurofibromatosis type 2), two originated in the trigeminal and one in the 12th nerves.
  • Three were intraspinal, one of this underwent malignant changes and was part of neurofibromatosis type 1 (NF-1), another was an intraspinal lumbar mass with schwannomatosis and the third was a case of multiple intraspinal neurofibromas as a part of NF-1.
  • The importance of early detection on intracranial and intraspinal peripheral tumors is paramount, since the large size of these histologically benign neoplasms makes them biologically malignant.
  • [MeSH-major] Brain Neoplasms / pathology. Cranial Nerve Neoplasms / pathology. Nerve Sheath Neoplasms / pathology. Spinal Cord Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Autopsy. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Neurilemmoma / pathology. Neurofibromatosis 1 / pathology. Neurofibromatosis 2 / pathology. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16883507.001).
  • [ISSN] 0210-0010
  • [Journal-full-title] Revista de neurologia
  • [ISO-abbreviation] Rev Neurol
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


49. Hughes MJ, Thomas JM, Fisher C, Moskovic EC: Imaging features of retroperitoneal and pelvic schwannomas. Clin Radiol; 2005 Aug;60(8):886-93
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The tumours were homogeneous in 5 cases and heterogeneous with cystic change in 8; in 2 cases there was smooth expansion of a sacral nerve root exit foramen, and in 1 there was bony destruction of the sacrum and extension of tumour into the spinal canal.
  • Although they are rare, it is important for the radiologist to recognize the typical appearance of schwannomas because they can be mistaken for malignant tumours.
  • [MeSH-major] Neurilemmoma / diagnosis. Pelvic Neoplasms / diagnosis. Retroperitoneal Neoplasms / diagnosis. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adult. Aged. Female. Humans. Incidental Findings. Magnetic Resonance Imaging. Male. Middle Aged. Muscle, Skeletal / pathology. Radiographic Image Enhancement. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16039924.001).
  • [ISSN] 0009-9260
  • [Journal-full-title] Clinical radiology
  • [ISO-abbreviation] Clin Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


50. Khouni H, Andrianne R, Nidhal H, Badreddine S, de Leval J, Faouzi MA: [Benign schwannoma, a rare retroperitoneal tumour]. Prog Urol; 2005 Feb;15(1):78-80
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Benign schwannoma, a rare retroperitoneal tumour].
  • Among retroperitoneal tumours derived from nervous tissue, schwannoma is defined as a tumour arising from neurilemma or Schwann nerve sheath cells.
  • Its diagnosis is immunohistological, and treatment is surgical, consisting of complete resection of the mass due to the risk of malignant degeneration.
  • The immunological and histological study concluded on benign schwannoma.
  • With a postoperative follow-up of two years, the patient has not presented any recurrence of this retroperitoneal schwannoma.
  • [MeSH-major] Neurilemmoma. Retroperitoneal Neoplasms
  • [MeSH-minor] Adult. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15822399.001).
  • [ISSN] 1166-7087
  • [Journal-full-title] Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
  • [ISO-abbreviation] Prog. Urol.
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


51. Carlson ML, Babovic-Vuksanovic D, Messiaen L, Scheithauer BW, Neff BA, Link MJ: Radiation-induced rhabdomyosarcoma of the brainstem in a patient with neurofibromatosis type 2. J Neurosurg; 2010 Jan;112(1):81-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neurofibromatosis Type 2 (NF2) is a rare autosomal dominant disorder characterized by the development of benign tumors of the peripheral nervous system and the CNS, including schwannomas, meningiomas, and ependymomas.
  • The gene responsible for the development of NF2 acts as a tumor suppressor gene.
  • Few reports exist of malignant peripheral nerve sheath tumors, meningiomas, or ependymomas occurring after SRT or stereotactic radiosurgery in patients with NF2.
  • Compared with patients with sporadic tumors, NF2 patients having a germline tumor suppressor gene defect may be more prone to secondary malignancies after treatment involving radiation therapy.
  • [MeSH-minor] Adult. Brain Neoplasms / etiology. Brain Neoplasms / surgery. Brain Stem / pathology. Brain Stem / radiation effects. Brain Stem / surgery. Ear Neoplasms / etiology. Ear Neoplasms / surgery. Fatal Outcome. Female. Humans. Neurilemmoma / etiology. Neurilemmoma / surgery. Vestibular Diseases / etiology. Vestibular Diseases / surgery

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • Genetic Alliance. consumer health - Neurofibromatosis type 2.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] J Neurosurg. 2010 Jan;112(1):209. Scheithauer, Bernd B [corrected to Scheithauer, Bernd W]
  • (PMID = 19575577.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


52. Kim MS, Park K, Kim JH, Kim YD, Lee JI: Gamma knife radiosurgery for orbital tumors. Clin Neurol Neurosurg; 2008 Dec;110(10):1003-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seven patients with preserved vision and tumors located near the optic nerve were treated with multisession (3 or 4 fractions) radiosurgery.
  • The mean tumor volume was 3695mm3 (737-13,300).
  • RESULTS: After a mean follow-up of 20.9 months (6-50), tumor control was confirmed in 12 of 15 patients.
  • Three patients with malignant lesions had to undergo another operation due to tumor progression.
  • Of the 13 patients whose preoperative vision was preserved, 6 patients showed improvement in visual acuity and/or visual field, 4 patients showed no change in vision, and 3 patients showed deterioration (2 related to tumor progression).
  • [MeSH-minor] Adult. Aged. Female. Follow-Up Studies. Hemangioma, Cavernous / pathology. Hemangioma, Cavernous / physiopathology. Hemangioma, Cavernous / surgery. Humans. Magnetic Resonance Imaging. Male. Meningioma / pathology. Meningioma / physiopathology. Meningioma / surgery. Middle Aged. Neurilemmoma / pathology. Neurilemmoma / physiopathology. Neurilemmoma / surgery. Optic Nerve Injuries / etiology. Optic Nerve Injuries / physiopathology. Optic Nerve Injuries / surgery. Postoperative Complications / etiology. Postoperative Complications / physiopathology. Postoperative Complications / surgery. Reoperation / methods. Retrospective Studies. Treatment Outcome. Vision, Low / etiology. Vision, Low / physiopathology. Vision, Low / surgery. Visual Fields / physiology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18653273.001).
  • [ISSN] 0303-8467
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


53. Liu WY, Chang CH, Tseng GC: Multiple penile schwannomas. MedGenMed; 2006;8(3):35

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The occurrence of penile schwannoma is very rare.
  • The largest tumor causing pain was excised.
  • Pathology was characteristic of benign schwannoma.
  • We recommend that penile schwannomas be excised if the tumors cause pain or are malignant.
  • [MeSH-major] Neoplasms, Multiple Primary / pathology. Neoplasms, Multiple Primary / surgery. Neurilemmoma / pathology. Neurilemmoma / surgery. Penile Neoplasms / pathology. Penile Neoplasms / surgery
  • [MeSH-minor] Adult. Erectile Dysfunction / etiology. Humans. Male. Pain / physiopathology. Penile Erection

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Urol. 2001 Feb;8(2):87-9 [11240833.001]
  • [Cites] Endocr Rev. 2001 Jun;22(3):342-88 [11399748.001]
  • [Cites] J Androl. 2003 Sep-Oct;24(5):651-2 [12954653.001]
  • [Cites] Cancer. 1970 Jun;25(6):1431-47 [4316326.001]
  • [Cites] J Urol. 1990 Jul;144(1):136-7 [2359163.001]
  • [Cites] J Urol. 1995 Jun;153(6):1931-2 [7752359.001]
  • [Cites] J Comput Assist Tomogr. 2006 Jan-Feb;30(1):68-9 [16365576.001]
  • (PMID = 17406168.001).
  • [ISSN] 1531-0132
  • [Journal-full-title] MedGenMed : Medscape general medicine
  • [ISO-abbreviation] MedGenMed
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1781298
  •  go-up   go-down


54. Fernández-Aceñero MJ, Larach F, Ortega-Fernández C: Non-epithelial lesions of the larynx: review of the 10-year experience in a tertiary Spanish hospital. Acta Otolaryngol; 2009 Jan;129(1):108-12

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We had two cases of chondrosarcoma, one case of liposarcoma, one case of synovial sarcoma, and one neural benign tumor, suggestive of neurinoma.
  • In this period we also had an inflammatory pseudotumor affecting the vocal cord, a case of primary laryngeal extramedullary plasmocytoma, and one case of high grade diffuse malignant lymphoma with exclusive involvement of the larynx.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Chondrosarcoma / pathology. Chondrosarcoma / radiotherapy. Chondrosarcoma / surgery. Female. Granuloma, Plasma Cell / pathology. Granuloma, Plasma Cell / radiotherapy. Granuloma, Plasma Cell / surgery. Humans. Liposarcoma / pathology. Liposarcoma / radiotherapy. Liposarcoma / surgery. Lymphoma, Non-Hodgkin / pathology. Lymphoma, Non-Hodgkin / radiotherapy. Lymphoma, Non-Hodgkin / surgery. Male. Middle Aged. Neurilemmoma / pathology. Neurilemmoma / radiotherapy. Neurilemmoma / surgery. Plasmacytoma / pathology. Plasmacytoma / radiotherapy. Plasmacytoma / surgery. Retrospective Studies. Sarcoma, Synovial / pathology. Sarcoma, Synovial / radiotherapy. Sarcoma, Synovial / surgery. Spain. Vocal Cords / pathology. Vocal Cords / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18607979.001).
  • [ISSN] 1651-2251
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


55. Lustgarten L, Abadi JR, Sancevic R, Meneses P, Perez Morrel A, Lugo J: Use of a protein-based tissue adhesive as an aid for the surgical reconstruction of advanced and recurrent skin cancer tumors to the head and neck region: a technical report. Surg Neurol; 2007 Jul;68(1):53-9; discussion 59
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathology included squamous (7) and basal (3) cell carcinoma and malignant schwannoma (1).
  • Three patients required additional brain resection because of tumor infiltration.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Brain / surgery. Carcinoma, Basal Cell / surgery. Carcinoma, Squamous Cell / surgery. Craniotomy. Dura Mater / surgery. Humans. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Neurilemmoma / surgery. Nose / surgery. Orbit / surgery. Postoperative Complications / mortality

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17586223.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bio-glue; 0 / Proteins; 0 / Tissue Adhesives
  •  go-up   go-down


56. White JB, Scheithauer BW, Amrami KK, Babovic-Vuksanovic D, Spinner RJ: Contiguous conventional and plexiform schwannomas. Report of two cases. J Neurosurg; 2006 Feb;104(2):319-24
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The authors present clinical, imaging, and histological features of two adult patients found to harbor a conventional schwannoma contiguous with a deep plexiform schwannoma.
  • The proximal forearm lesions consisted of a conventional schwannoma and an underlying plexiform component.
  • The authors believe that a more careful examination of patients with NF2 may show that these people have a higher incidence of plexiform schwannoma than previously thought.
  • Pathological confirmation is crucial in distinguishing plexiform schwannomas from plexiform neurofibromas, because the latter are directly associated with NF1 and have a significant tendency to undergo malignant transformation.
  • To the best of the authors' knowledge, this is the first report of a conventional schwannoma contiguous with a deep plexiform schwannoma.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningioma / pathology. Neurilemmoma / pathology. Neurofibroma, Plexiform / pathology. Neurofibromatosis 2 / complications
  • [MeSH-minor] Adult. Arm / innervation. Arm / pathology. Cell Transformation, Neoplastic. Functional Laterality. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16509508.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


57. Ben Brahim E, Ferchiou M, Khayat O, Zribi S, M'barek C, Labbène N, El Khedim A, Ben Ayed M, Chadli-Debbiche A: [Tumors of salivary glands: anatomical study and clinical epidemiology of a series of 180 cases]. Tunis Med; 2010 Apr;88(4):240-4
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Benign tumors were predominant (88%), while malignant ones represented 12% of our cases dominated by carcinomas.
  • Parotid gland location was the most frequent one, and pleomorphic adenoma was the most frequent tumor (62%).
  • [MeSH-minor] Adenoma / epidemiology. Adenoma / pathology. Adolescent. Adult. Aged. Carcinoma / epidemiology. Carcinoma / pathology. Child. Child, Preschool. Female. Humans. Lipoma / epidemiology. Lipoma / pathology. Lymphangioma / epidemiology. Lymphangioma / pathology. Male. Middle Aged. Neurilemmoma / epidemiology. Neurilemmoma / pathology. Neurofibroma / epidemiology. Neurofibroma / pathology. Tunisia / epidemiology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20446256.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Tunisia
  •  go-up   go-down


58. Wan B, Wang L, Zhu Y, Ma S, Xie W: [Clinical analysis of 33 cases of neurilemmomas of the head and neck]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Sep;21(17):794-5
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One case with malignant tumor were died.
  • CONCLUSION: Tumor resection is still the most effective treatment available for patients with neurilemmomas of the head and neck.
  • Resection of tumor should be performed as soon as possible with careful protection of the function of the nerve.
  • Extensive resection should be performed to treat malignant tumors.
  • [MeSH-major] Head and Neck Neoplasms. Neurilemmoma
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Male. Middle Aged. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17993019.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


59. Klijanienko J, Caillaud JM, Lagacé R: Cytohistologic correlations in schwannomas (neurilemmomas), including "ancient," cellular, and epithelioid variants. Diagn Cytopathol; 2006 Aug;34(8):517-22
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schwannoma accounts for one of the most common benign mesenchymal neoplasms of soft tissues.
  • No example of melanotic schwannoma was recorded.
  • Original cytologic diagnosis was schwannoma in 13 (38.2%) cases, benign soft tissue tumor in 11 (32.4%), pleomorphic adenoma in 2 (6%) cases, angioma in 1 (2.9%) case, nodular fasciitis in 1 (2.9%) case, suspicious in 3 (8.8%) cases, and not satisfactory in 3 (8.8%) cases.
  • Schwannoma should be differentiated from well-differentiated malignant peripheral nerve sheath tumor, neurofibroma, and pleomorphic adenoma, in the last instance particularly for head and neck lesions.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Neurilemmoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Reproducibility of Results

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16850489.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Aron M, Kapila K, Verma K: Neural tumours of the neck presenting as thyroid nodules: a report of three cases. Cytopathology; 2005 Aug;16(4):206-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report two cases of schwannoma and one case of a malignant peripheral nerve sheath tumour (MPNST) of the neck, which presented as thyroid nodules and evaluate the role of cytology in identifying these tumours.
  • RESULTS: Both the cases of schwannoma were correctly identified on cytology while the case of MPNST could only be typed as a spindle cell tumour.
  • CONCLUSIONS: Schwannomas of the neck are easily identifiable on cytology compared with MPNST.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Nerve Sheath Neoplasms / diagnosis. Neurilemmoma / diagnosis. Thyroid Gland / pathology
  • [MeSH-minor] Adult. Cytodiagnosis. Diagnosis, Differential. Female. Goiter, Nodular / diagnosis. Humans. Male

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16048507.001).
  • [ISSN] 0956-5507
  • [Journal-full-title] Cytopathology : official journal of the British Society for Clinical Cytology
  • [ISO-abbreviation] Cytopathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


61. Joseph JA, Jaberoo MC, Sandison A, Grant WE: Benign schwannoma of the tonsil. BMJ Case Rep; 2010;2010
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign schwannoma of the tonsil.
  • Tonsillar schwannoma is a slow growing lesion presenting in the third to fifth decade of life.
  • Tonsillar schwannoma can be diagnosed in the outpatient clinic.
  • Schwannoma has the potential for malignant transformation, with no recorded cases of this occurring in the tonsil.
  • [MeSH-major] Neurilemmoma / pathology. Neurilemmoma / surgery. Tonsillar Neoplasms / pathology. Tonsillar Neoplasms / surgery
  • [MeSH-minor] Biopsy, Needle. Deglutition Disorders / diagnosis. Deglutition Disorders / etiology. Dysphonia / diagnosis. Dysphonia / etiology. Follow-Up Studies. Humans. Immunohistochemistry. Male. Rare Diseases. Risk Assessment. Tomography, X-Ray Computed / methods. Tonsillectomy / methods. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Laryngol Otol. 1999 Jun;113(6):585-6 [10605596.001]
  • [Cites] J Oral Maxillofac Surg. 2001 Jul;59(7):802-4 [11429745.001]
  • [Cites] Otolaryngol Head Neck Surg. 2002 Jun;126(6):693-4 [12087340.001]
  • [Cites] J Indian Med Assoc. 1975 Jul 1;65(1):17-8 [1184990.001]
  • [Cites] Br J Oral Maxillofac Surg. 1993 Feb;31(1):32-5 [8431412.001]
  • [Cites] Am J Surg Pathol. 1994 Sep;18(9):882-95 [8067509.001]
  • [Cites] J Laryngol Otol. 2005 Jul;119(7):570-2 [16175987.001]
  • [Cites] Ear Nose Throat J. 2007 Jun;86(6):354-5 [17703816.001]
  • [Cites] Sao Paulo Med J. 2007 Jul 5;125(4):220-2 [17992392.001]
  • (PMID = 22767561.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3029798
  •  go-up   go-down


62. Dong Z, Yang Z, Li Y, Min P, Zhang X: [Extra-organic primary tumor in pelvis: correlation of multi-detector row computed tomography, anatomy and pathology]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb;26(1):75-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Extra-organic primary tumor in pelvis: correlation of multi-detector row computed tomography, anatomy and pathology].
  • Calcification occurred in 6 cases, including 4 cases of teratoma, 1 case of neurilemmoma, and 1 case of malignant teratoma.
  • The fatty element occurred in 7 masses, including 4 cases of teratoma, 1 case of malignant teratoma, 1 case of mixed germ cell tumor, and 1 case of liposarcoma.
  • MDCT with multi-planar reconstruction (MPR) could more clearly reveal the anatomic location of the extra-organic primary tumor in pelvis, could unveil the tumor's relationship with its surrounding organs, and could help to differentiate benign tumors from malignant tumors.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Imaging, Three-Dimensional. Infant. Male. Middle Aged. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19334559.001).
  • [ISSN] 1001-5515
  • [Journal-full-title] Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi
  • [ISO-abbreviation] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


63. Knight DM, Birch R, Pringle J: Benign solitary schwannomas: a review of 234 cases. J Bone Joint Surg Br; 2007 Mar;89(3):382-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In these, a nerve repair was performed in 18 and treatment for pain or paralysis was offered to another 14.
  • No case of malignant transformation was seen.
  • [MeSH-major] Neurilemmoma / surgery. Peripheral Nervous System Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biopsy. Bone Neoplasms / pathology. Bone Neoplasms / physiopathology. Bone Neoplasms / surgery. Brachial Plexus Neuropathies / pathology. Brachial Plexus Neuropathies / physiopathology. Brachial Plexus Neuropathies / surgery. Child. Female. Humans. Male. Middle Aged. Muscle Neoplasms / pathology. Muscle Neoplasms / physiopathology. Muscle Neoplasms / surgery. Pain / physiopathology. Postoperative Complications. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17356155.001).
  • [ISSN] 0301-620X
  • [Journal-full-title] The Journal of bone and joint surgery. British volume
  • [ISO-abbreviation] J Bone Joint Surg Br
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


64. Tahir MZ, Fatimi SH, Enam SA: Ancient schwannoma presenting as a thoracic mass. Surg Neurol; 2007 Nov;68(5):534-6
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ancient schwannoma presenting as a thoracic mass.
  • BACKGROUND: Ancient schwannoma is a rare variant of schwannoma, histologically showing atypical features that may result in erroneous diagnosis of a malignant tumor.
  • CASE DESCRIPTION: We report a case of a 34-year-old man who was found to have giant mediastinal tumor.
  • He underwent thoracotomy to remove the mass, which was proven to be ancient schwannoma on histopathology.
  • [MeSH-major] Neurilemmoma / pathology. Neurilemmoma / surgery. Spinal Neoplasms / pathology. Spinal Neoplasms / surgery. Thoracic Vertebrae
  • [MeSH-minor] Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17765953.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Trufant JW, Brenn T, Fletcher CD, Virata AR, Cook DL, Bosenberg MW: Melanotic schwannoma arising in association with nevus of Ota: 2 cases suggesting a shared mechanism. Am J Dermatopathol; 2009 Dec;31(8):808-13
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanotic schwannoma arising in association with nevus of Ota: 2 cases suggesting a shared mechanism.
  • Melanotic schwannoma is a rare markedly pigmented peripheral nerve sheath tumor comprising cells with prominent melanization and schwannian features.
  • We present the first 2 reported cases of melanotic schwannoma arising in patients with a history of nevus of Ota, a rare dermal melanosis believed to represent a failure of melanocyte migration to the epidermis during embryogenesis.
  • Case 1 involves a 40-year-old woman with a 1.8-cm, deeply pigmented, trigeminal nerve mass and pigmentation of the maxillary sinus mucosa and bone.
  • Microscopically, both masses consist of partially encapsulated epithelioid and spindle cells with abundant melanin pigment, arising in association with peripheral nerves.
  • Morphological, immunohistochemical, and ultrastructural features support a diagnosis of melanotic schwannoma.
  • Melanotic schwannoma is most often benign but has been associated with malignant behavior in some cases.
  • Distinguishing this nerve sheath tumor from malignant melanoma can be difficult but is of great clinical importance due to differences in prognosis and treatment.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Neurilemmoma / pathology. Nevus of Ota / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Immunohistochemistry. Melanins. Middle Aged

  • Genetic Alliance. consumer health - Nevus.
  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19786855.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Melanins
  •  go-up   go-down


66. Siqueira MG, Martins RS, Teixeira MJ: Management of brachial plexus region tumours and tumour-like conditions: relevant diagnostic and surgical features in a consecutive series of eighteen patients. Acta Neurochir (Wien); 2009 Sep;151(9):1089-98
MedlinePlus Health Information. consumer health - Brachial Plexus Injuries.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FINDINGS: The tumours comprised a heterogeneous group of lesions, including schwannomas, neurofibromas, malignant peripheral nerve sheath tumour (MPNST), sarcomas, metastases, desmoids and an aneurysmal bone cyst.
  • Eleven tumours were benign and 7 were malignant.
  • Some of the malignant tumours could be controlled by surgery plus adjuvant therapy, but this category is still associated with high morbidity and mortality rates.
  • [MeSH-major] Brachial Plexus / pathology. Brachial Plexus / surgery. Brachial Plexus Neuropathies / diagnosis. Brachial Plexus Neuropathies / surgery. Peripheral Nervous System Neoplasms / diagnosis. Peripheral Nervous System Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Bone Cysts, Aneurysmal / diagnosis. Bone Cysts, Aneurysmal / pathology. Bone Cysts, Aneurysmal / surgery. Child. Female. Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / physiopathology. Fibromatosis, Aggressive / surgery. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Metastasis / diagnosis. Neoplasm Metastasis / physiopathology. Neoplasm Recurrence, Local / epidemiology. Nerve Sheath Neoplasms / diagnosis. Nerve Sheath Neoplasms / physiopathology. Nerve Sheath Neoplasms / surgery. Neurilemmoma / diagnosis. Neurilemmoma / physiopathology. Neurilemmoma / surgery. Neurofibroma / diagnosis. Neurofibroma / physiopathology. Neurofibroma / surgery. Neurosurgical Procedures. Pain / etiology. Paresthesia / etiology. Postoperative Complications / epidemiology. Retrospective Studies. Sarcoma / diagnosis. Sarcoma / physiopathology. Sarcoma / surgery. Tomography, X-Ray Computed. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19448970.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


67. Yang CY, Chou CW, Lin MB, Li CF: Schwannomas of the left adrenal gland and posterior mediastinum. J Chin Med Assoc; 2009 Feb;72(2):83-7
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schwannoma is a rare tumor of neural crest cell origin.
  • Pathologic studies showed a picture of benign schwannoma.
  • In conclusion, preoperative differentiation of benign schwannoma from malignant peripheral nerve sheath tumor or other tumors is important for good prognosis.
  • Total excision of benign schwannoma is associated with favourable outcome in patients.
  • [MeSH-major] Adrenal Gland Neoplasms / diagnosis. Mediastinal Neoplasms / diagnosis. Neurilemmoma / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Magnetic Resonance Imaging. Radiography, Thoracic. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19251536.001).
  • [ISSN] 1726-4901
  • [Journal-full-title] Journal of the Chinese Medical Association : JCMA
  • [ISO-abbreviation] J Chin Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


68. Wasa J, Nishida Y, Suzuki Y, Tsukushi S, Shido Y, Hosono K, Shimoyama Y, Nakamura S, Ishiguro N: Differential expression of angiogenic factors in peripheral nerve sheath tumors. Clin Exp Metastasis; 2008;25(7):819-25

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of angiogenic factors in peripheral nerve sheath tumors.
  • It is difficult to differentiate some malignant peripheral nerve sheath tumors (MPNST) from benign peripheral nerve sheath tumors (BPNST) histologically, and to predict the clinical outcome of patients with MPNST.
  • In this study, the expression of VEGF and MVD were evaluated immunohistochemically in 22 cases of MPNST, 14 of neurofibroma and 19 of schwannoma and correlation of the staining grade of VEGF or MVD and the various clinical factors were analyzed, and statistically evaluated.
  • Statistically higher positive staining for VEGF was observed in MPNST compared to neurofibroma (P=0.004) and schwannoma (P<0.001).
  • Even low grade MPNST showed higher VEGF positive staining than neurofibroma.
  • Moreover, high VEGF expression statistically correlated with the poor prognosis of the patients with MPNST (P=0.015).
  • Although MVD in MPNST was significantly higher than that in neurofibroma (P=0.038) and schwannoma (P<0.001), MVD could not predict the prognosis of the patients with MPNST.
  • Although VEGF mRNA expression tended to be higher in MPNST compared to neurofibroma, the difference was not significant.
  • Levels of VEGF protein expression serve as a novel diagnostic and prognostic tools for peripheral nerve sheath tumors.
  • [MeSH-major] Nerve Sheath Neoplasms / chemistry. Vascular Endothelial Growth Factor A / analysis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neurilemmoma / blood supply. Neurilemmoma / chemistry. Neurofibroma / blood supply. Neurofibroma / chemistry. RNA, Messenger / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18679811.001).
  • [ISSN] 0262-0898
  • [Journal-full-title] Clinical & experimental metastasis
  • [ISO-abbreviation] Clin. Exp. Metastasis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Vascular Endothelial Growth Factor A
  •  go-up   go-down


69. Chan PT, Tripathi S, Low SE, Robinson LQ: Case report--ancient schwannoma of the scrotum. BMC Urol; 2007;7:1
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case report--ancient schwannoma of the scrotum.
  • BACKGROUND: Scrotal schwannoma is a rare neoplasm and poses a diagnostic challenge to urologists.
  • This article describes a rare case of ancient scrotal schwannoma and reviews the current modality of investigation and treatment of this tumour.
  • Surgical excision was undertaken and histology was an ancient schwannoma of the scrotum.
  • CONCLUSION: Schwannoma is a benign encapsulating neoplasm with an overall low incidence, occurring mostly in the head and neck region and seldom in the scrotum.
  • Variations of schwannoma such as cellular, ancient, glandular and epithelioid are observed based on the appearances.
  • Ancient schwannoma exhibits pleomorphism without mitosis as the result of cellular degeneration, which can lead to an erroneous diagnosis of malignancy.
  • Malignant change is exceedingly rare.
  • [MeSH-major] Genital Neoplasms, Male / diagnosis. Genital Neoplasms, Male / therapy. Neurilemmoma / diagnosis. Neurilemmoma / therapy
  • [MeSH-minor] Adult. Humans. Male. Scrotum

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Craniomaxillofac Surg. 2006 Jan;34(1):38-42 [16343919.001]
  • [Cites] Hinyokika Kiyo. 2002 Dec;48(12):749-51 [12613010.001]
  • [Cites] J Korean Med Sci. 2003 Apr;18(2):295-8 [12692434.001]
  • [Cites] Urology. 2003 Dec;62(6):993-7 [14665342.001]
  • [Cites] Pancreatology. 2004;4(6):505-8 [15316226.001]
  • [Cites] J R Soc Med. 1992 Jul;85(7):416-7 [1629853.001]
  • [Cites] Actas Urol Esp. 1997 Nov-Dec;21(10):1012-3 [9494170.001]
  • [Cites] Urol Int. 1998;60(3):202-4 [9644798.001]
  • [Cites] AJR Am J Roentgenol. 2004 Aug;183(2):331-6 [15269020.001]
  • (PMID = 17244372.001).
  • [ISSN] 1471-2490
  • [Journal-full-title] BMC urology
  • [ISO-abbreviation] BMC Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 10
  • [Other-IDs] NLM/ PMC1783662
  •  go-up   go-down


70. Ndiaye M, Rouleau V, Rame JP, Pescatori P, Denoux Y, Louis MY, De Raucourt D: [Laryngeal schwannoma: a case report and review of the literature]. Rev Laryngol Otol Rhinol (Bord); 2006;127(4):243-6
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Laryngeal schwannoma: a case report and review of the literature].
  • OBJECTIVES: In presenting a case of laryngeal schwannoma, the authors emphasize the difficulties in diagnosing this rare pathology and review treatment options.
  • MATERIALS AND METHOD: The authors present a case of laryngeal schwannoma in a 29 year old man, revealed by exertional inspiratory dyspnea.
  • The possibility of malignant change and recurrence warrant long-term follow-up.
  • [MeSH-major] Laryngeal Neoplasms / pathology. Neurilemmoma / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Dyspnea / etiology. Humans. Laryngectomy. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17315789.001).
  • [ISSN] 0035-1334
  • [Journal-full-title] Revue de laryngologie - otologie - rhinologie
  • [ISO-abbreviation] Rev Laryngol Otol Rhinol (Bord)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


71. Habib T, Hamdi JT, Hussain W, Almiamini W, Hamdi K, Wani AM, Al Zeyani NR: Presacral schwannoma treated as irritable bowel syndrome. BMJ Case Rep; 2010;2010
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Presacral schwannoma treated as irritable bowel syndrome.
  • Presacral tumours represent a heterogeneous group of predominantly benign and occasionally malignant neoplasms.
  • Schwannomas of the presacral region are one variant described as benign tumours of neurogenic origin.
  • The case of a large presacral schwannoma in a 26-year-old man, who was treated for irritable bowel syndrome for 4 years, is presented.
  • The tumour was resected and histology revealed it to be a schwannoma.
  • [MeSH-major] Delayed Diagnosis. Diagnostic Errors. Irritable Bowel Syndrome / diagnosis. Neurilemmoma / diagnosis
  • [MeSH-minor] Adult. Constipation / etiology. Diagnosis, Differential. Humans. Male. Sacrococcygeal Region

  • Genetic Alliance. consumer health - Irritable Bowel Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Colon Rectum. 1985 Sep;28(9):644-52 [2996861.001]
  • [Cites] Br J Surg. 1986 Feb;73(2):153-5 [3947908.001]
  • [Cites] World J Gastroenterol. 2007 Apr 14;13(14):2129-31 [17465461.001]
  • [Cites] Clin Med Res. 2008 May;6(1):9-16 [18591372.001]
  • [Cites] Mil Med. 2008 Aug;173(8):814-6 [18751604.001]
  • [Cites] BJOG. 2009 Jan;116(1):129; author reply 129-30 [19087090.001]
  • [Cites] Cir Cir. 2009 Sep-Oct;77(5):397-401 [19944030.001]
  • [Cites] Surg Clin North Am. 2010 Feb;90(1):163-71, Table of Contents [20109640.001]
  • (PMID = 22791578.001).
  • [ISSN] 1757-790X
  • [Journal-full-title] BMJ case reports
  • [ISO-abbreviation] BMJ Case Rep
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Video-Audio Media
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC3038043
  •  go-up   go-down


72. Salla JT, Johann AC, Garcia BG, Aguiar MC, Mesquita RA: Retrospective analysis of oral peripheral nerve sheath tumors in Brazilians. Braz Oral Res; 2009 Jan-Mar;23(1):43-8
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retrospective analysis of oral peripheral nerve sheath tumors in Brazilians.
  • Traumatic neuroma, neurofibroma, neurilemmoma, palisaded encapsulated neuroma and malignant peripheral nerve sheath tumor (MPNST) are peripheral nerve sheath tumors and present neural origin.
  • The goal of this study was to describe the epidemiological data of oral peripheral nerve sheath tumors in a sample of the Brazilian population.
  • Lesions diagnosed as peripheral nerve sheath tumors were submitted to morphologic and to immunohistochemical analyses.
  • Thirty-five oral peripheral nerve sheath tumors were found, representing 0.16% of all lesions archived in the Oral Pathology Service.
  • Neurilemmoma (4 cases) was more commonly observed in the buccal mucosa.
  • Malignant peripheral nerve sheath tumors (3 cases) occurred in the mandible, palate, and tongue.
  • The data confirmed that oral peripheral nerve sheath tumors are uncommon in the oral region, with some lesions presenting a predilection for a specific gender or site.
  • This study may be useful in clinical dentistry and oral pathology practice and may be used as baseline data regarding oral peripheral nerve sheath tumors in other populations.
  • [MeSH-major] Mouth Neoplasms / epidemiology. Nerve Sheath Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biopsy. Brazil / epidemiology. Child. Female. Humans. Immunohistochemistry. Male. Middle Aged. Retrospective Studies. S100 Proteins / analysis. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19488471.001).
  • [ISSN] 1807-3107
  • [Journal-full-title] Brazilian oral research
  • [ISO-abbreviation] Braz Oral Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / S100 Proteins
  •  go-up   go-down


73. Cheng JW, Tang SF, Yu TY, Chou SW, Wong AM, Tsai WC: Sonographic features of soft tissue tumors in the hand and forearm. Chang Gung Med J; 2007 Nov-Dec;30(6):547-54

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The mobility, consistency, echogenicity, margin, and color Doppler signal of each tumor were assessed.
  • RESULTS: The pathologic diagnoses of these soft tissue lesions were lipoma (n = 6), ganglion cyst (n = 6), neurilemmoma (n = 3), neurofibroma (n = 3), giant cell tumor (n = 10), tenosynovitis (n = 2), and malignant lymphoma (n = 1).
  • An adjacent tendon or communication duct extending to the joint space could be found in most giant cell tumors and ganglion cysts; a traceable nerve could be found in most nerve sheath tumors.
  • The only malignant tumor appeared ill-defined without a color Doppler signal.
  • [MeSH-minor] Adult. Aged. Female. Ganglion Cysts / ultrasonography. Giant Cell Tumors / ultrasonography. Humans. Lipoma / ultrasonography. Male. Middle Aged. Nerve Sheath Neoplasms / ultrasonography. Retrospective Studies. Tenosynovitis / ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18350738.001).
  • [ISSN] 2072-0939
  • [Journal-full-title] Chang Gung medical journal
  • [ISO-abbreviation] Chang Gung Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


74. Andrade ES, Filho JR, Rocha NS, Neto IC, Camargo IB: Isolated intra-oral granular cell tumor: report of two cases and review of the literature. Acta Odontol Latinoam; 2010;23(2):99-104

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated intra-oral granular cell tumor: report of two cases and review of the literature.
  • Granular cell tumor (GCT) is a relatively uncommon lesion occurring in almost any part of the body, including the orofacial region.
  • Although aggressive and malignant variants of this neoplasm have been described, most GCTs are benign.
  • The tumor generally occurs in middle-aged or older adults.
  • Differential diagnoses include fibrous hyperplasia, minor salivary gland tumor condyloma acuminatum and neurilemmoma.
  • The main clinical pathology and diagnostic features of this neoplasm are reviewed and discussed.
  • [MeSH-major] Granular Cell Tumor / pathology. Tongue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21053681.001).
  • [ISSN] 0326-4815
  • [Journal-full-title] Acta odontológica latinoamericana : AOL
  • [ISO-abbreviation] Acta Odontol Latinoam
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Argentina
  •  go-up   go-down


75. Wang W, Montgomery E, Epstein JI: Benign nerve sheath tumors on urinary bladder biopsy. Am J Surg Pathol; 2008 Jun;32(6):907-12
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign nerve sheath tumors on urinary bladder biopsy.
  • Benign nerve sheath tumors (schwannoma and neurofibroma) involving the urinary bladders are rare with only case reports and limited series.
  • Both cases with schwannoma had only bladder involvement.
  • Neither recurrence nor malignant transformation was demonstrated on follow-up.
  • [MeSH-major] Nerve Sheath Neoplasms / pathology. Neurilemmoma / pathology. Neurofibroma / pathology. Urinary Bladder Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Biopsy. Child. Child, Preschool. Female. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18425043.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ, Lunsford LD: Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery; 2007 Mar;60(3):460-8; discussion 468-70
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates.
  • We evaluated the results of gamma knife radiosurgery for the management of these tumors, focusing on tumor response, hearing preservation, and other factors affecting outcomes.
  • The mean tumor volume was 5.7 cm3.
  • Tumor volume was significant as a predictor of local control.
  • Radiation dose and tumor volume were predictive of development of new deficits.
  • No radiosurgery-associated secondary tumors or atypical or malignant changes were noted.
  • Although results do not seem to be as good as for patients with sporadic unilateral tumors, gamma knife radiosurgery results seem favorable and indicate that radiosurgery should be strongly considered for primary tumor management in selected patients.
  • [MeSH-major] Hearing Loss, Sensorineural / epidemiology. Hearing Loss, Sensorineural / prevention & control. Neurilemmoma / epidemiology. Neurilemmoma / surgery. Neurofibromatosis 2 / epidemiology. Neurofibromatosis 2 / surgery. Radiosurgery / statistics & numerical data
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Female. Humans. Incidence. Male. Middle Aged. Pennsylvania / epidemiology. Retrospective Studies. Risk Assessment / methods. Risk Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • Genetic Alliance. consumer health - Neurofibromatosis type 2.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17327790.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


77. Domanski HA, Akerman M, Rissler P, Gustafson P: Fine-needle aspiration of soft tissue leiomyosarcoma: an analysis of the most common cytologic findings and the value of ancillary techniques. Diagn Cytopathol; 2006 Sep;34(9):597-604
Genetic Alliance. consumer health - Leiomyosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An unequivocal, malignant diagnosis was rendered by FNAC in 78 cases; 74 tumors were diagnosed as sarcoma, of which 31 as LMS or suspicion of LMS.
  • In addition, three smears were labeled as malignant tumor, one as carcinoma metastasis, and three as neurilemmoma.
  • On reevaluation, the diagnostic smears in most cases contained tumor cell fascicles with an admixture of dispersed cells or stripped nuclei.
  • Thus, most high-grade LMSs have cytologic features that allow diagnosis of sarcoma.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Staging. Reproducibility of Results

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2006 Wiley-Liss, Inc.
  • (PMID = 16900474.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


78. Xiong Z, Cao Y, Guo D, Ye F, Lei T: Expression of EGFR and LRIG-1 in human trigeminal neurinoma. J Huazhong Univ Sci Technolog Med Sci; 2006;26(1):86-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It was suggested that LRIG-1 might inhibit the malignant differentiation and proliferation of the trigeminal neurinoma possibly by the negative feedback loop of EGFR.
  • [MeSH-major] Cranial Nerve Neoplasms / metabolism. Membrane Glycoproteins / biosynthesis. Neurilemmoma / metabolism. Receptor, Epidermal Growth Factor / biosynthesis. Trigeminal Nerve Diseases / metabolism
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16711015.001).
  • [ISSN] 1672-0733
  • [Journal-full-title] Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
  • [ISO-abbreviation] J. Huazhong Univ. Sci. Technol. Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / LRIG1 protein, human; 0 / Membrane Glycoproteins; EC 2.7.10.1 / Receptor, Epidermal Growth Factor
  •  go-up   go-down


79. Domanski HA, Akerman M, Engellau J, Gustafson P, Mertens F, Rydholm A: Fine-needle aspiration of neurilemoma (schwannoma). A clinicocytopathologic study of 116 patients. Diagn Cytopathol; 2006 Jun;34(6):403-12
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine-needle aspiration of neurilemoma (schwannoma). A clinicocytopathologic study of 116 patients.
  • There were 6 false-positive malignant diagnoses while 23 smears were considered insufficient and 7 inconclusive as to whether benign or malignant.
  • Furthermore aspirates showing predominantly Antoni A features, nuclear pleomorphism, and/or myxoid changes can easily be confused with other types of benign or malignant soft-tissue tumors.
  • [MeSH-major] Biopsy, Fine-Needle. Neurilemmoma / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Diagnosis, Differential. False Positive Reactions. Female. Humans. Male. Middle Aged. S100 Proteins / metabolism. Sarcoma / pathology. Sensitivity and Specificity

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16680779.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / S100 Proteins
  •  go-up   go-down


80. Braunschweig F, Kramer MF, Assmann G, Arbogast S, Leunig A: [Schwannoma of the nasal cavity: a case report]. HNO; 2007 Dec;55(13):1013-6
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Schwannoma of the nasal cavity: a case report].
  • It is very important to distinguish between schwannoma and primary benign neurofibroma.
  • Neurofibromas are lesions having the possibility for malignant transformation and recurrence.
  • A case of schwannoma in the nasal cavity is reported, and the diagnostic and therapeutic procedures, as well as recommendations from the literature, are described.
  • The histological and immunohistochemical features are discussed in detail to draw a distinction between schwannoma and neurofibroma.
  • In cases of intranasal and paranasal lesions, the existence of a schwannoma must be considered.
  • Differentiating between schwannoma and neurofibroma is important for estimating the risk of malignant transformation and recurrence.
  • [MeSH-major] Nasal Cavity / pathology. Neurilemmoma / pathology. Neurofibroma / pathology. Nose Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ear Nose Throat J. 2003 Aug;82(8):634-6, 638, 640 [14503104.001]
  • [Cites] Br J Radiol. 2006 Jul;79(943):e16-8 [16823047.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2000;257(7):402-5 [11052256.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 1993;114(1):33-6 [8191048.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1993;423(5):401-5 [8116230.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2003 Apr;260(4):195-7 [12709802.001]
  • [Cites] J Clin Neuroophthalmol. 1984 Dec;4(4):259-63 [6240501.001]
  • [Cites] Neurosurgery. 1986 Nov;19(5):813-5 [3785631.001]
  • [Cites] J Laryngol Otol. 2001 Dec;115(12):1012-4 [11779336.001]
  • [Cites] Am J Rhinol. 2002 Mar-Apr;16(2):113-8 [12030357.001]
  • [Cites] Otolaryngol Head Neck Surg. 2005 Jun;132(6):963-4 [15944574.001]
  • [Cites] Rhinology. 2001 Sep;39(3):169-72 [11721510.001]
  • [Cites] Curr Opin Neurol. 2002 Dec;15(6):679-84 [12447105.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1982 Jan-Feb;91(1 Pt 1):65-9 [7073181.001]
  • [Cites] Arq Neuropsiquiatr. 2001 Jun;59(2-B):421-3 [11460191.001]
  • [Cites] Acta Otolaryngol Suppl. 1993;504:151-4 [8470524.001]
  • [Cites] Ear Nose Throat J. 2006 Jun;85(6):384-5 [16866114.001]
  • [Cites] Otolaryngol Head Neck Surg. 2005 Sep;133(3):458-9 [16143202.001]
  • [Cites] Arch Otolaryngol. 1974 Nov;100(5):383-5 [4429486.001]
  • [Cites] Cancer. 1975 Apr;35(4):1254-8 [803868.001]
  • (PMID = 17874054.001).
  • [ISSN] 1433-0458
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 22
  •  go-up   go-down


81. De Waele M, Carp L, Lauwers P, Hendriks J, De Maeseneer M, Van Schil P, Blockx P: Paravertebral schwannoma with high uptake of fluorodeoxyglucose on positron emission tomography. Acta Chir Belg; 2005 Sep-Oct;105(5):537-8
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paravertebral schwannoma with high uptake of fluorodeoxyglucose on positron emission tomography.
  • CT, MRI and fine needle aspiration cytology (FNAC) pointed in the direction of a benign mass, but positron emission tomography (PET) showed a high uptake of [(18)F]fluorodeoxyglucose (FDG), which was indicative of a malignant lesion.
  • Pathological analysis of the thoracoscopically resected tumour gave us the final diagnosis of a benign schwannoma.
  • This report demonstrates that a high uptake of FDG in a non-malignant mediastinal tumour is possible.
  • [MeSH-major] Neurilemmoma / radionuclide imaging. Spinal Neoplasms / radionuclide imaging
  • [MeSH-minor] Adult. Female. Fluorodeoxyglucose F18. Humans. Positron-Emission Tomography. Radiopharmaceuticals

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16315843.001).
  • [ISSN] 0001-5458
  • [Journal-full-title] Acta chirurgica Belgica
  • [ISO-abbreviation] Acta Chir. Belg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


82. Oxner CR, Shinners MJ, Godin DA, Lyn IT, Brent RB, McFadden PM: Obstructing tracheobronchial schwannoma. J La State Med Soc; 2005 May-Jun;157(3):159-61
MedlinePlus Health Information. consumer health - Choking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Obstructing tracheobronchial schwannoma.
  • Endotracheal and endobronchial schwannomas are extremely rare tumors of neurogenic origin.
  • Two cases of tracheobronchial schwannoma with proximal airway obstruction are reported.
  • Because malignant transformation is exceedingly rare, operative resection of tracheobronchial schwannomas based on the principle of conservation of lung parenchyma is emphasized.
  • [MeSH-major] Airway Obstruction / etiology. Neurilemmoma / diagnosis. Tracheal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Biopsy. Bronchoscopy. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Schwannoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16173316.001).
  • [ISSN] 0024-6921
  • [Journal-full-title] The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society
  • [ISO-abbreviation] J La State Med Soc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Misra MC, Bhattacharjee HK, Hemal AK, Bansal VK: Laparoscopic management of rare retroperitoneal tumors. Surg Laparosc Endosc Percutan Tech; 2010 Jun;20(3):e117-22

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Due to their close proximity to major vessels, large size, variable location, and unknown malignant status, retroperitoneal tumors are frequently managed by open surgical exploration.
  • The histology reported retroperitoneal ganglioneuroma, retroperitoneal schwannoma, and retroperitoneal paraganglioma.
  • There has been no tumor recurrence at a mean follow-up of 39 months.
  • [MeSH-major] Ganglioneuroma / surgery. Laparoscopy. Neurilemmoma / surgery. Paraganglioma / surgery. Retroperitoneal Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20551790.001).
  • [ISSN] 1534-4908
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Ozawa H, Kokubun S, Aizawa T, Hoshikawa T, Kawahara C: Spinal dumbbell tumors: an analysis of a series of 118 cases. J Neurosurg Spine; 2007 Dec;7(6):587-93
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fifteen (18%) of the 81 schwannomas were observed in the C-2 nerve root, thus having a higher incidence than those in the other nerve roots.
  • Of 118 cases, 69% of the tumors were schwannomas, and malignant tumors were found in 10 cases (8.5%).
  • Seven (64%) of 11 patients younger than 10 years of age had malignant tumors.
  • Three patients older than 10 years of age had malignant tumors, thus accounting for 2.8% of the 107 older patients.
  • Malignant dumbbell tumors were more common in children younger than 10 years of age than in older patients.
  • [MeSH-major] Laminectomy / methods. Magnetic Resonance Imaging. Peripheral Nervous System Neoplasms / epidemiology. Spinal Cord Neoplasms / epidemiology. Spinal Neoplasms / epidemiology. Spinal Nerve Roots
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Cervical Vertebrae. Child. Child, Preschool. Female. Humans. Incidence. Infant. Lumbar Vertebrae. Male. Middle Aged. Neurilemmoma / diagnosis. Neurilemmoma / epidemiology. Sex Distribution. Thoracic Vertebrae

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18074682.001).
  • [ISSN] 1547-5654
  • [Journal-full-title] Journal of neurosurgery. Spine
  • [ISO-abbreviation] J Neurosurg Spine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Qu H, Wang CF, Zhao P, Shan Y, Zhao DB: [Local resection of pancreatic neoplasms: clinical analysis of 17 cases]. Zhonghua Yi Xue Za Zhi; 2008 May 27;88(20):1405-7
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathological examination confirmed 8 tumors as nonfunctioning insulinoma, 5 as solid pseudopapillary tumor, 1 as neurilemmoma, 1 as cyst, 1 as gastrointestinal stroma tumor, and 1 as low-graded malignant tumor.
  • CONCLUSION: Capable pf preserving endocrine and exocrine functions, local resection is a feasible method for benign or low-graded malignant pancreatic neoplasms, however, with a high rate of pancreatic leakage.
  • [MeSH-minor] Adult. Aged. Feasibility Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prognosis. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18953880.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


86. Kim CS, Suh MW: Skull base surgery for removal of temporal bone tumors. Acta Otolaryngol Suppl; 2007 Oct;(558):4-14

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSION: When selecting the appropriate surgical approach the pathological type of tumor, the physiological status as well as the functional aspects should be considered.
  • Understanding the strengths and weaknesses of each surgical technique and knowledge of the particular tumor biology facilitates selection of the most appropriate surgical approach and a successful outcome.
  • A facial nerve schwannoma was the most common benign intratemporal tumor and a squamous cell carcinoma was the most common malignant tumor.
  • With the facial nerve schwannoma, facial nerve paralysis and hearing loss were the most common presenting complaints; otalgia was the most common presenting symptom for temporal bone cancer.
  • For patients with a glomus tumor, there was a characteristic pulsating tinnitus.
  • A majority of the facial nerve schwannomas were resectable through the transmastoid approach.
  • The infratemporal fossa approach type A was usually required for lower cranial nerve schwannomas and glomus jugulare tumors.
  • [MeSH-minor] Adolescent. Adult. Cerebrospinal Fluid Otorrhea / etiology. Child. Child, Preschool. Cranial Nerve Neoplasms / surgery. Dizziness / etiology. Earache / etiology. Facial Nerve Diseases / surgery. Facial Paralysis / etiology. Female. Glomus Tumor / blood supply. Glomus Tumor / surgery. Hearing Loss / etiology. Hoarseness / etiology. Humans. Infant. Male. Middle Aged. Muscle Weakness. Neurilemmoma / surgery. Retrospective Studies. Tinnitus / etiology. Vertigo / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17882564.001).
  • [ISSN] 0365-5237
  • [Journal-full-title] Acta oto-laryngologica. Supplementum
  • [ISO-abbreviation] Acta Otolaryngol Suppl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  •  go-up   go-down


87. Chetty R, Vajpeyi R, Penwick JL: Psammomatous melanotic schwannoma presenting as colonic polyps. Virchows Arch; 2007 Sep;451(3):717-20
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Psammomatous melanotic schwannoma presenting as colonic polyps.
  • Psammomatous melanotic schwannoma is an uncommon neoplasm that usually occurs in the setting of Carney's complex.
  • The tumor was diffusely positive for S-100, and focally for HMB-45 and melan-A.
  • The differential diagnosis includes melanoma, GIST, pigmented neuroendocrine tumor, and epithelioid leiomyoma.
  • The lack of malignant features separates this lesion from melanoma while the immunophenotype of the other lesions is characteristic.
  • [MeSH-major] Colonic Neoplasms / pathology. Colonic Polyps / pathology. Neurilemmoma / pathology
  • [MeSH-minor] Adult. Colonoscopy. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Immunophenotyping. Leiomyoma, Epithelioid. Melanins / analysis. Melanoma. Neuroendocrine Tumors. Pigmentation

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 2001 Jul;25(7):846-55 [11420455.001]
  • [Cites] Ann Diagn Pathol. 2003 Aug;7(4):254-8 [12913850.001]
  • [Cites] Hum Pathol. 1988 Mar;19(3):257-64 [3126126.001]
  • [Cites] Histopathology. 2001 Nov;39(5):493-7 [11737307.001]
  • [Cites] J Clin Invest. 1996 Feb 1;97(3):699-705 [8609225.001]
  • [Cites] Medicine (Baltimore). 1985 Jul;64(4):270-83 [4010501.001]
  • [Cites] Lancet Oncol. 2005 Jul;6(7):501-8 [15992699.001]
  • [Cites] Am J Surg Pathol. 1999 Apr;23(4):431-6 [10199472.001]
  • [Cites] Am J Surg Pathol. 1990 Mar;14(3):206-22 [2305928.001]
  • [Cites] J Gastroenterol. 1998 Dec;33(6):872-5 [9853563.001]
  • [Cites] Am J Surg Pathol. 1991 Aug;15(8):722-31 [2069210.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14222-7 [15371594.001]
  • [Cites] Dis Colon Rectum. 1998 Sep;41(9):1193-6 [9749505.001]
  • (PMID = 17622556.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Melanins
  •  go-up   go-down


88. Xia SY, Li R, Song SB, Liang FQ: [Diagnosis and surgical therapy of primary retroperitoneal neurogenic tumors]. Zhonghua Yi Xue Za Zhi; 2009 Jun 9;89(22):1567-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis and surgical therapy of primary retroperitoneal neurogenic tumors].
  • OBJECTIVE: To explore the diagnosis and surgical therapy for retroperitoneal neurogenic tumors (PRNTs).
  • METHODS: The clinical records of 79 surgically treated patients with retroperitoneal neurogenic tumor were retrospectively analyzed.
  • Pathological analysis identified 19 patients with neurofibroma, 8 with neurilemmoma, 4 with paraganglioma, 21 with neurofibrosarcoma, 14 with malignant neurilemmoma, 6 with malignant paraganglioma, 5 with neuroectodermal tumor and 2 with neuroblastoma.
  • The mortality rate of PRNT operation is was 1.3%, 3-year recurrence rate of benign tumor 0%, 5-year recurrence rate of benign tumor 12.9%, reoperation rate 100%, 5-year survival rate 100%.
  • 3 years recurrence rate of malignancy tumor 41.6%, reoperation rate 90%, 5 years recurrence rate of malignancy tumor 79.1% and 5 years survival rate is 62.5%.
  • Pre-operative preparation of intestinal tract and blood, maintaining the intactness of involved nerve are important for tumor resection.
  • To prevent tumor recurrence, the key surgical techniques are to minimize tumor residues and .
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Prognosis. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19953887.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


89. Chijiwa H, Mihoki T, Shin B, Sakamoto K, Umeno H, Nakashima T: Clinical study of parapharyngeal space tumours. J Laryngol Otol Suppl; 2009;(31):100-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Seventy-seven per cent of the parapharyngeal space tumours were benign and 23 per cent were malignant.
  • A mandibular swing approach was used for one malignant tumour.
  • The most common complication, facial nerve paralysis, was identified in eight patients, and seven of these patients demonstrated first bite syndrome.
  • [MeSH-major] Adenoma, Pleomorphic / surgery. Cranial Nerve Neoplasms / surgery. Neurilemmoma / surgery. Parotid Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Facial Nerve Injuries / etiology. Female. Glossopharyngeal Nerve. Glossopharyngeal Nerve Diseases / surgery. Humans. Hypoglossal Nerve. Hypoglossal Nerve Diseases / surgery. Male. Middle Aged. Pain / etiology. Postoperative Complications / etiology. Syndrome. Vagus Nerve. Vagus Nerve Diseases / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19460214.001).
  • [ISSN] 0144-2945
  • [Journal-full-title] The Journal of laryngology and otology. Supplement
  • [ISO-abbreviation] J Laryngol Otol Suppl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


90. Lai TK, Chung CH, Chin AC, Szeto PS, Wong WC, Chan RY, Huang HY, Ng WF: Magnetic resonance imaging for ureteral fibroepithelial polyp. Hong Kong Med J; 2008 Oct;14(5):408-10
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ureteric tumours are rare and most of them are malignant.

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18840916.001).
  • [ISSN] 1024-2708
  • [Journal-full-title] Hong Kong medical journal = Xianggang yi xue za zhi
  • [ISO-abbreviation] Hong Kong Med J
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


91. Suchak R, Luzar B, Bacchi CE, Maguire B, Calonje E: Cutaneous neuroblastoma-like schwannoma: a report of two cases, one with a plexiform pattern, and a review of the literature. J Cutan Pathol; 2010 Sep;37(9):997-1001
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous neuroblastoma-like schwannoma: a report of two cases, one with a plexiform pattern, and a review of the literature.
  • Neuroblastoma-like schwannoma was first described by Goldblum et al. in 1994, and very few cases have since been reported.
  • It is a benign sporadic neoplasm with no reported association with neurofibromatosis, and is characterized histologically by small round lesional cells surrounding collagenous cores forming rosette-like structures.
  • The differential diagnosis includes other lesions with the formation of rosettes including neuroblastoma, low-grade fibromyxoid sarcoma and dendritic cell neurofibroma, as well as primitive neuroectodermal tumors and rare malignant transformation in a schwannoma.
  • [MeSH-major] Neurilemmoma / pathology. Neuroblastoma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / metabolism. Female. Humans. Treatment Outcome

  • Genetic Alliance. consumer health - Neuroblastoma.
  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19922484.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


92. Subhashraj K, Balanand S, Pajaniammalle S: Ancient schwannoma arising from mental nerve. A case report and review. Med Oral Patol Oral Cir Bucal; 2009 Jan;14(1):E12-4
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ancient schwannoma arising from mental nerve. A case report and review.
  • Schwannoma is an intraoral rare, benign neoplasm derived from the nerve sheath of peripheral nerves.
  • "Ancient schwannoma" shows histopathological features, such as degenerative changes and atypical nuclei, and may easily be confused with malignant neoplasms.
  • Ancient schwannoma of the head and neck region is relatively uncommon and very few cases had been reported in the oral cavity.
  • We present a case of ancient schwannoma arising from the mental nerve in a 19 year old male which was of eight months duration.
  • Ultrasonography showed that the tumor was closely associated with the mental nerve on the left side, suggestive of a peripheral neural sheath tumor.
  • Complete excision of the lesion was done under local anesthesia, preserving the mental nerve.
  • The histological picture was strongly suggestive of ancient schwannoma (Antoni A type).
  • [MeSH-major] Chin / innervation. Neurilemmoma / pathology. Peripheral Nervous System Neoplasms / pathology
  • [MeSH-minor] Humans. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19114949.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 11
  •  go-up   go-down


93. Zhang R, Zhou LF, Mao Y: [Microsurgical treatment of nonmeningeal tumors of the cavernous sinus]. Zhonghua Yi Xue Za Zhi; 2005 Jun 1;85(20):1373-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The main clinical presentation included cranial nerve paralysis (47 cases, 70.1%), neuroendocrine symptoms (11 cases, 16.4%), eye pain (9 cases, 13.6%), proptosis (7 cases, 10.6%), limb weakness (5 cases, 7.5%), headache, dizziness, lethargy, and temporal lobe epilepsy (4 cases each), and epistaxis (1 case).
  • Pathological examination revealed that hemangioma (24 cases), trigeminal schwannoma (18 cases), and invasive pituitary adenomas (11 cases) comprised the majority of tumors; the remaining tumor types were chordoma, chondroma, chondromyosarcoma, chondrofibroma, dermoid tumor, malignant nerve sheath tumor, metastatic tumor, and lymphoma.
  • In the intradural approach group, total tumor removal was achieved in 8 cases (40%), and 7 (35%) cases and 5 (25%) cases had subtotal and partial resection respectively.
  • In the epidural approach group, 27 cases (81.8%) had total tumor removal, while 1 case (3.0%) had subtotal and 5 cases had partial excision of the tumor.
  • The aggressive or new symptoms mainly included paralysis of oculomotor nerve (13 cases, 19.4%), trigeminal nerve (9 cases, 13.4%), and abduct nerve (9 cases, 13.4%).
  • CONCLUSION: Depending on pathologic type and growth pattern of the tumor, extended middle skull base epidural or epidural-transdural approach is selected.
  • Such techniques can offer satisfactory outcome, protecting the cranial nerve functions and removing the tumor to the maximum extent.
  • [MeSH-major] Central Nervous System Neoplasms / surgery. Cranial Nerve Neoplasms / surgery. Hemangioma, Cavernous, Central Nervous System / surgery. Microsurgery. Trigeminal Nerve Diseases / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Cavernous Sinus / surgery. Child. Diagnosis, Differential. Female. Humans. Male. Middle Aged. Neurilemmoma / diagnosis. Neurilemmoma / surgery. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16029646.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


94. Sheikh HY, Chakravarthy RP, Slevin NJ, Sykes AJ, Banerjee SS: Benign schwannoma in paranasal sinuses: a clinico-pathological study of five cases, emphasising diagnostic difficulties. J Laryngol Otol; 2008 Jun;122(6):598-602
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign schwannoma in paranasal sinuses: a clinico-pathological study of five cases, emphasising diagnostic difficulties.
  • OBJECTIVES: To highlight the difficulty in making a correct diagnosis of benign schwannoma in the paranasal region, to raise awareness of this rare condition, and to suggest the most appropriate treatment.
  • Radiological appearances of local bone invasion and histological features of tumour unencapsulation and hypercellularity could give the mistaken impression of malignant disease and lead to unnecessary over-treatment.
  • [MeSH-major] Ethmoid Sinus / pathology. Neurilemmoma / pathology. Paranasal Sinus Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. England. Female. Humans. Male. Maxillary Sinus Neoplasms / pathology. Maxillary Sinus Neoplasms / radiography. Maxillary Sinus Neoplasms / surgery. Middle Aged. Retrospective Studies. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17705894.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


95. Ducic Y, Oxford L, Pontius AT: Transoral approach to the superomedial parapharyngeal space. Otolaryngol Head Neck Surg; 2006 Mar;134(3):466-70
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Eight patients with various neoplasms of the superomedial PPS were retrospectively reviewed for type of neoplasm, size, success with the transoral approach, need for conversion to another approach, length of hospitalization, and complications.
  • The most common pathology encountered was that of schwannoma.
  • Mean tumor size was 3.3 cm (range, 1.5 to 7 cm).
  • This approach alone may not provide adequate access for resection of malignant lesions especially those with extension intracranially or to more inferior or laterally placed lesions of the parapharyngeal space.
  • [MeSH-minor] Adolescent. Adult. Biopsy, Needle. Carotid Artery, Internal / pathology. Child. Female. Follow-Up Studies. Humans. Intraoperative Care. Length of Stay. Male. Middle Aged. Neoplasm Invasiveness. Neurilemmoma / pathology. Neurilemmoma / surgery. Postoperative Complications. Retrospective Studies. Teratoma / pathology. Teratoma / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16500446.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Xu D, Liu D, Zhang Z, Zhang Y, Li Y, Liu X, Jia Q, Zheng L, Song G: Gamma Knife surgery in the management of orbital tumors. J Neurosurg; 2010 Dec;113 Suppl:34-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 84 meningiomas, 38 epithelial tumors of the lacrimal gland, 23 schwannomas, 18 malignant choroidal melanomas, 12 optic nerve gliomas, 11 orbital metastases, 10 pseudotumors of the orbit, 3 retinoblastomas, and 3 cases of fibromatosis.
  • The tumor margin dose ranged from 10 to 40 Gy.
  • RESULTS: At a median follow-up period of 34.5 ± 14.7 months (range 12-114 months), tumor shrinkage was observed in 118 patients (58.4%) and stable tumor size in 71 patients (35.1%).
  • Regularly scheduled neuroimaging studies demonstrated evidence of tumor progression in only 13 patients (6.4%): 9 of these patients underwent repeated GKS and 4 received surgical treatment.
  • [MeSH-major] Meningioma / surgery. Neurilemmoma / surgery. Optic Nerve Glioma / surgery. Orbital Neoplasms / surgery. Radiosurgery / instrumentation
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Child, Preschool. Disease-Free Survival. Female. Humans. Male. Meningeal Neoplasms / surgery. Middle Aged. Radiotherapy Dosage. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21121785.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Saraswathy A, Jayasree RS, Baiju KV, Gupta AK, Pillai VP: Optimum wavelength for the differentiation of brain tumor tissue using autofluorescence spectroscopy. Photomed Laser Surg; 2009 Jun;27(3):425-33
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimum wavelength for the differentiation of brain tumor tissue using autofluorescence spectroscopy.
  • OBJECTIVE: The role of autofluorescence spectroscopy in the detection and staging of benign and malignant brain tumors is being investigated in this study, with an additional aim of determining an optimum excitation wavelength for the spectroscopic identification of brain tumors.
  • MATERIALS AND METHODS: The present study involves in-vitro autofluorescence monitoring of different human brain tumor samples to assess their spectroscopic properties.
  • The autofluorescence measurement at four different excitation wavelengths 320, 370, 410, and 470 nm, were carried out for five different brain tumor types: glioma, astrocytoma, meningioma, pituitary adenoma, and schwannoma.
  • RESULTS: The fluorescence spectra of tumor tissues showed significant differences, both in intensity and in spectral profile, from those of adjacent normal brain tissues at all four excitation wavelengths.
  • Of the four excitation wavelengths being considered, 470 nm appeared to be the optimal wavelength for detecting tissue fluorescence of brain tumor tissues.
  • CONCLUSIONS: In conclusion, the spectroscopic luminescence measurements carried out in this study revealed significant differences between tumor tissue and adjacent normal tissue of human brains for all the tumor types tested, except for pituitary adenoma.
  • From the results of this study we conclude that excitation wavelengths ranging from 410-470 nm are most suitable for the detection of brain tumor tissue.
  • [MeSH-minor] Adolescent. Adult. Aged. Algorithms. Astrocytoma / pathology. Child. Child, Preschool. Discriminant Analysis. Female. Glioma / pathology. Humans. Male. Meningioma / pathology. Middle Aged. Neoplasm Staging. Neurilemmoma / pathology. Pituitary Neoplasms / pathology. Principal Component Analysis

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19025404.001).
  • [ISSN] 1557-8550
  • [Journal-full-title] Photomedicine and laser surgery
  • [ISO-abbreviation] Photomed Laser Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


98. Uesaka T, Shono T, Suzuki SO, Nakamizo A, Niiro H, Mizoguchi M, Iwaki T, Sasaki T: Expression of VEGF and its receptor genes in intracranial schwannomas. J Neurooncol; 2007 Jul;83(3):259-66
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We found that these tumors expressed significant amounts of VEGF mRNA in comparison with other brain tumors, including malignant gliomas and meningiomas.
  • When we divided patients into two groups according to VEGF mRNA expression in the tumor, there was no significant difference in patient age, gender, or cranial nerves of origin between groups; however, the tumor volume tended to be larger in the high VEGF group than in the low VEGF group.
  • [MeSH-major] Brain Neoplasms / genetics. Gene Expression Regulation, Neoplastic. Neurilemmoma / genetics. Vascular Endothelial Growth Factor A / genetics. Vascular Endothelial Growth Factor Receptor-1 / genetics. Vascular Endothelial Growth Factor Receptor-2 / genetics
  • [MeSH-minor] Adult. Aged. Antigens, Neoplasm / metabolism. Astrocytoma / genetics. Astrocytoma / metabolism. Astrocytoma / pathology. Cranial Nerve Neoplasms / genetics. Cranial Nerve Neoplasms / metabolism. Cranial Nerve Neoplasms / pathology. DNA Topoisomerases, Type II / metabolism. DNA-Binding Proteins / metabolism. Female. Glioblastoma / genetics. Glioblastoma / metabolism. Glioblastoma / pathology. Humans. Immunoenzyme Techniques. Male. Meningioma / genetics. Meningioma / metabolism. Meningioma / pathology. Middle Aged. Neoplasm Recurrence, Local / genetics. Neoplasm Recurrence, Local / metabolism. Neoplasm Recurrence, Local / pathology. Neurofibromin 2 / genetics. RNA, Messenger / metabolism. RNA, Neoplasm / genetics. RNA, Neoplasm / metabolism. Reverse Transcriptase Polymerase Chain Reaction / methods. Ubiquitin-Protein Ligases / metabolism

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17570036.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / DNA-Binding Proteins; 0 / Neurofibromin 2; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / VEGFA protein, human; 0 / Vascular Endothelial Growth Factor A; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-1; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2; EC 5.99.1.3 / DNA Topoisomerases, Type II; EC 5.99.1.3 / DNA topoisomerase II alpha; EC 6.3.2.19 / MIB1 ligase, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


99. Gelly-Marty M, Martin E, Assous D, Cuisenier J, Collin F: [Plexiform schwannoma of the delto-pectoral area]. Ann Pathol; 2007 Apr;27(2):133-5
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Plexiform schwannoma of the delto-pectoral area].
  • Plexiform schwannoma is a form of schwannoma which usually involves cutaneous tissues.
  • It cannot be easily differentiated from malignant tumors, especially deep or cellular lesions.
  • We report a deep plexiform schwannoma which we place among the various benign or malignant nerve sheath tumors, which may or may not develop within the context of genetic disease.
  • [MeSH-major] Neurilemmoma / pathology. Soft Tissue Neoplasms / pathology. Thoracic Wall
  • [MeSH-minor] Humans. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17909473.001).
  • [ISSN] 0242-6498
  • [Journal-full-title] Annales de pathologie
  • [ISO-abbreviation] Ann Pathol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


100. Chiofalo MG, Longo F, Marone U, Franco R, Petrillo A, Pezzullo L: Cervical vagal schwannoma. A case report. Acta Otorhinolaryngol Ital; 2009 Feb;29(1):33-5
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cervical vagal schwannoma. A case report.
  • Schwannoma originating from the cervical vagus nerve is an extremely rare neoplasm.
  • Vagal nerve schwannoma usually occurs between the third and fifth decades of life, it does not show sex predilection both sexes being equally affected and it most often presents as a painless, slow-growing, lateral neck mass.
  • A case of a cervical vagal schwannoma, in a 33-year old male with a previous medical history of malignant lymphoma, is described.
  • The clinical features, diagnosis, management and pathological findings of cervical vagal schwannoma are discussed.
  • [MeSH-major] Cranial Nerve Neoplasms. Neurilemmoma. Vagus Nerve Diseases
  • [MeSH-minor] Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Laryngol Otol. 2000 Feb;114(2):119-24 [10748827.001]
  • [Cites] Neurosurgery. 2000 Jun;46(6):1498-503 [10834653.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Sep;123(3):334-6 [10964317.001]
  • [Cites] Acta Otolaryngol. 2002 Jun;122(4):435-7 [12126003.001]
  • [Cites] J Otolaryngol. 2003 Feb;32(1):61-3 [12779265.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2007 Jul;133(7):662-7 [17638778.001]
  • [Cites] J Otolaryngol. 1985 Jun;14(3):167-70 [4068112.001]
  • [Cites] Laryngoscope. 1988 Jun;98(6 Pt 1):648-54 [2836676.001]
  • [Cites] Head Neck. 1991 Sep-Oct;13(5):439-41 [1938363.001]
  • [Cites] Laryngoscope. 1996 Dec;106(12 Pt 1):1548-52 [8948621.001]
  • [Cites] Laryngoscope. 1984 Jul;94(7):946-9 [6738275.001]
  • (PMID = 19609380.001).
  • [ISSN] 1827-675X
  • [Journal-full-title] Acta otorhinolaryngologica Italica : organo ufficiale della Società italiana di otorinolaringologia e chirurgia cervico-facciale
  • [ISO-abbreviation] Acta Otorhinolaryngol Ital
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2689565
  • [Keywords] NOTNLM ; Benign tumours / Magnetic Resonance imaging / Schwannoma / Vagus nerve
  •  go-up   go-down






Advertisement